Exempt Chemical Preparations Under the Controlled Substances Act, 40175-40186 [2013-16010]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
changes in market demand abroad).
Demand conditions to consider include
end uses and applications; the existence
and availability of substitute products;
and the level of competition among the
Domestic Like Product produced in the
United States, Subject Merchandise
produced in the Subject Country, and
such merchandise from other countries.
(13) (OPTIONAL) A statement of
whether you agree with the above
definitions of the Domestic Like Product
and Domestic Industry; if you disagree
with either or both of these definitions,
please explain why and provide
alternative definitions.
Authority: This review is being conducted
under authority of Title VII of the Tariff Act
of 1930; this notice is published pursuant to
section 207.61 of the Commission’s rules.
Issued: June 25, 2013.
By order of the Commission.
William R. Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2013–16103 Filed 7–2–13; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1103–NEW]
Agency Information Collection
Activities; Proposed New Collection;
Comments Requested: Police-Led
Diversion Programs: National
Prevalence and Scope
emcdonald on DSK67QTVN1PROD with NOTICES
ACTION:
60-Day Notice.
The Department of Justice (DOJ)
Office of Community Oriented Policing
Services (COPS) will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The proposed
information collection is published to
obtain comments from the public and
affected agencies. The purpose of this
notice is to allow for 60 days for public
comment until September 3, 2013. This
process is conducted in accordance with
5 CFR 1320.10.
If you have comments, especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Danielle Ouellette,
Department of Justice Office of
Community Oriented Policing Services,
145 N Street NE., Washington, DC
20530.
Written comments and suggestions
from the public and affected agencies
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Proposed new collection; comments
requested
(2) Title of the Form/Collection:
Police-Led Diversion Programs: National
Prevalence and Scope
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
None. U.S. Department of Justice Office
of Community Oriented Policing
Services
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Law enforcement agencies
through a nationally representative
sample may be asked to provide
information to determine the national
prevalence of police-led diversion
programs and provide a portrait of their
goals, target populations, and policies.
Through a cooperative agreement with
the COPS Office, the Center for Court
Innovation (CCI, Inc.) will create a
representative sample of law
enforcement agencies based on data
available through the FBI Uniform
Crime Reporting. CCI will subcontract
with a professional survey research firm
to administer the survey.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that 3,600
respondents annually will complete the
form in approximately 1 hour.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 3,600
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
40175
total annual burden hours associated
with this collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Room 1407B,
Washington, DC 20530.
June 27, 2013.
Jerri Murray,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. 2013–15904 Filed 7–2–13; 8:45 am]
BILLING CODE 4410–AT–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–372]
Exempt Chemical Preparations Under
the Controlled Substances Act
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Order with opportunity for
comment.
AGENCY:
The applications for exempt
chemical preparations received by DEA
between July 1, 2012, and March 31,
2013, as listed below, were accepted for
filing and have been approved or denied
as indicated.
DATES: Electronic comments must be
submitted and written comments must
be postmarked on or before September
3, 2013. The electronic Federal Docket
Management System will not accept
comments after midnight Eastern Time
on the last day of the comment period.
ADDRESSES: To ensure proper handling
of comments, please reference ‘‘Docket
No. DEA–372’’ on all electronic and
written correspondence. DEA
encourages that all comments be
submitted electronically through https://
www.regulations.gov using the
electronic comment form provided on
that site. An electronic copy of this
document is also available at https://
www.regulations.gov for easy reference.
Paper comments that duplicate the
electronic submission are not necessary
as all comments submitted to
www.regulations.gov will be posted for
public review and are part of the official
docket record. Written comments
submitted via regular or express mail
should be sent to the Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODL, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
E:\FR\FM\03JYN1.SGM
03JYN1
40176
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
John
W. Partridge, Executive Assistant, Office
of Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 307–7165.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
Posting of Public Comments
Please note that all comments
received are considered part of the
public record and made available for
public inspection online at https://
www.regulations.gov and in the DEA’s
public docket. Such information
includes personal identifying
information (such as your name,
address, etc.) voluntarily submitted by
the commenter.
If you want to submit personal
identifying information (such as your
name, address, etc.) as part of your
comment, but do not want it to be
posted online or made available in the
public docket, you must include the
phrase ‘‘PERSONAL IDENTIFYING
INFORMATION’’ in the first paragraph
of your comment. You must also place
all the personal identifying information
you do not want posted online or made
available in the public docket in the first
paragraph of your comment and identify
what information you want redacted.
If you want to submit confidential
business information as part of your
comment, but do not want it to be
posted online or made available in the
public docket, you must include the
phrase ‘‘CONFIDENTIAL BUSINESS
INFORMATION’’ in the first paragraph
of your comment. You must also
prominently identify confidential
business information to be redacted
within the comment. If a comment has
so much confidential business
information that it cannot be effectively
redacted, all or part of that comment
may not be posted online or made
available in the public docket.
Personal identifying information and
confidential business information
identified and located as set forth above
will be redacted, and the comment, in
redacted form, will be posted online and
placed in DEA’s public docket file.
Please note that the Freedom of
Information Act applies to all comments
received. If you wish to inspect the
agency’s public docket file in person by
appointment, please see the FOR
FURTHER INFORMATION CONTACT
paragraph.
Legal Authority
DEA implements and enforces Titles
II and III of the Comprehensive Drug
Abuse Prevention and Control Act of
1970, often referred to as the Controlled
Substances Act and the Controlled
Substances Import and Export Act
(codified at Title 21, Chapter 13 of the
U.S.C.), as amended (CSA). DEA drafts
and publishes the implementing
regulations for these statutes in Title 21
of the Code of Federal Regulations
(CFR), parts 1300 to 1321. The CSA and
its implementing regulations are
designed to prevent, detect, and
eliminate the diversion of controlled
substances and listed chemicals into the
illicit market while providing for a
sufficient supply of controlled
substances and listed chemicals for
legitimate medical, scientific, research,
and industrial purposes. Controlled
substances have the potential for abuse
and dependence and are controlled to
protect the public health and safety.
Section 201 of the CSA (21 U.S.C.
811) authorizes the Attorney General, by
regulation, to exempt from certain
provisions of the CSA certain
compounds, mixtures, or preparations
containing a controlled substance, if he
finds that such compounds, mixtures, or
preparations meet the requirements
detailed in 21 U.S.C. 811(g)(3)(B).1 DEA
regulations at 21 CFR 1308.23 and
1308.24 further detail the criteria by
which the DEA Deputy Assistant
Administrator may exempt a chemical
preparation or mixture from the
application of certain provisions of the
CSA. The Deputy Assistant
Administrator may, pursuant to 21 CFR
1308.23(f), modify or revoke the criteria
by which exemptions are granted and
modify the scope of exemptions at any
time.
Exempt Chemical Preparation
Applications Submitted Between July 1,
2012, and March 31, 2013
The Deputy Assistant Administrator
received applications between July 1,
2012, and March 31, 2013, requesting
exempt chemical preparation status
pursuant to 21 CFR 1308.23. Pursuant to
the criteria stated in 21 U.S.C.
811(g)(3)(B) and in 21 CFR 1308.23, the
Deputy Assistant Administrator has
found that each of the compounds,
mixtures, and preparations described in
Chart I below is intended for laboratory,
industrial, educational, or special
research purposes and not for general
administration to a human being or
other animal and either: (1) Contains no
narcotic controlled substance and is
packaged in such a form or
concentration that the packaged
quantity does not present any
significant potential for abuse; or (2)
contains either a narcotic or nonnarcotic controlled substance and one or
more adulterating or denaturing agents
in such a manner, combination,
quantity, proportion, or concentration
that the preparation or mixture does not
present any potential for abuse; if the
preparation or mixture contains a
narcotic controlled substance, it must be
formulated in such a manner that it
incorporates methods of denaturing or
other means so that the preparation or
mixture is not liable to be abused or
have ill effects if abused, and so that the
narcotic substance cannot in practice be
removed.
Accordingly, pursuant to 21 U.S.C.
811(g)(3)(B), 21 CFR 1308.23, and 21
CFR 1308.24, the Deputy Assistant
Administrator has determined that each
of the chemical preparations or mixtures
generally described in Chart I below and
specifically described in the application
materials received by DEA, are exempt,
to the extent described in 21 CFR
1308.24, from application of sections
302, 303, 305, 306, 307, 308, 309, 1002,
1003, and 1004 (21 U.S.C. 822–823,
825–829, and 952–954) of the CSA, and
21 CFR 1301.74, as of the date listed
below that was provided in the approval
letters to the individual requesters.
CHART I
emcdonald on DSK67QTVN1PROD with NOTICES
Supplier
AccuStandard,
AccuStandard,
AccuStandard,
AccuStandard,
AccuStandard,
Inc
Inc
Inc
Inc
Inc
...................
...................
...................
...................
...................
Product name
APP–9–086, a,a-Dimethylphenethylamine ..............................
APP–9–086–20X, a,a-Dimethylphenethylamine ......................
AS–E1179, Chloral hydrate .....................................................
CLP–HC–X1, Composite Mix #3A ...........................................
M–551.1B, Disinfectant by-products ........................................
1 This authority has been delegated from the
Attorney General to the Administrator of the DEA
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
by 28 CFR 0.100 and subsequently redelegated to
PO 00000
Frm 00088
Fmt 4703
Application
date
Form
Sfmt 4703
Amber
Amber
Amber
Amber
Amber
ampule:
ampule:
ampule:
ampule:
ampule:
1
1
1
1
1
mL
mL
mL
mL
mL
..............
..............
..............
..............
..............
1/28/2013
1/28/2013
1/28/2013
1/28/2013
1/28/2013
the Deputy Assistant Administrator pursuant to the
Appendix to Subpart R of 28 CFR 0.104.
E:\FR\FM\03JYN1.SGM
03JYN1
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
40177
CHART I—Continued
Application
date
Supplier
Product name
Form
AccuStandard, Inc ...................
AccuStandard, Inc ...................
AccuStandard, Inc ...................
AccuStandard, Inc ...................
AccuStandard, Inc ...................
AccuStandard, Inc ...................
AccuStandard, Inc ...................
AccuStandard, Inc ...................
Agilent Technologies ...............
Agilent Technologies ...............
Agilent Technologies ...............
Agilent Technologies ...............
Agilent Technologies ...............
Agilent Technologies ...............
Agilent Technologies ...............
Alltech Associates, Inc ............
Alltech Associates, Inc ............
Alltech Associates, Inc ............
American Proficiency Institute
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Bio-Rad Laboratories ..............
Bio-Rad Laboratories ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Glass ampule: 1 mL ...............
Glass ampule: 1 mL ...............
Glass ampule: 1 mL ...............
Amber bottle: 7 mL .................
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Box: 3 vials, 2.5 mL each .......
Box: 12 vials, 5 mL each ........
1/28/2013
1/28/2013
1/28/2013
1/28/2013
1/28/2013
1/28/2013
1/28/2013
1/28/2013
8/3/2012
8/3/2012
8/3/2012
8/3/2012
8/3/2012
8/3/2012
12/6/2012
9/26/2012
9/26/2012
9/26/2012
12/5/2012
8/14/2012
8/14/2012
9/27/2012
10/23/2012
10/23/2012
11/5/2012
1/24/2013
1/24/2013
1/29/2013
3/12/2013
3/12/2013
3/14/2013
11/14/2012
11/21/2012
Box: 6 vials, 5 mL each ..........
Box: 3 vials, 5 mL each ..........
Glass vial: 25 mL ....................
11/21/2012
11/21/2012
1/11/2013
Bio-Rad Laboratories ..............
M–551B, Disinfectant by-products ...........................................
M–551B–2, Chloral hydrate .....................................................
M–8015B/5031–21, Paraldehyde .............................................
M–8206B–05, Additional VOC’s by Method 8206B .................
M–8270–02, Semi-Volatile by Capillary Column GC/MS Mix 2
M–8270–04–ASL, Method 8270B—Base/Neutrals Mix ...........
M–8270–23–R1, Method 8270 Semi-Volatile Additions ..........
M–E–1179–M, Chloral hydrate ................................................
Veterinary Drugs Checkout Mix ...............................................
Veterinary Drugs Comprehensive Mix—Submix 6 ..................
Forensic Toxicology Comprehensive Mix—Submix 3 .............
Forensic Toxicology Comprehensive Mix—Submix 5 .............
Forensic Toxicology Comprehensive Mix—Submix 2 .............
Forensic Toxicology Checkout Mix ..........................................
Forensic Toxicology Comprehensive Mix—Submix 1 .............
2C–T–2 Quik Check, 1.0 mg/mL .............................................
5-MeO–DMT Quick Check, 1.0 mg/mL ...................................
Carisoprodol Quik Check, 1.0 mg/mL ......................................
American Proficiency Institute SHBG/Testosterone ................
Detectabuse Custom Liquid Control Oral Fluid, OF23 ............
Detectabuse Custom Liquid Control Urine, SD17 ...................
Detectabuse Custom Liquid Control Urine, MC176 ................
Detectabuse Custom Liquid Control Urine, MC179 ................
Salivabuse Custom Liquid Control Oral Fluid, OF25 ..............
Detectabuse Custom Liquid Control Urine, MC177 ................
Detectabuse Custom Liquid Control Urine, MC178 ................
Detectabuse Custom Liquid Control Oral Fluid, OF24 ............
Detectabuse Custom Liquid Control Urine, MC181 ................
Detectabuse Custom Liquid Control Urine, MC183 ................
Detectabuse Custom Liquid Control Urine, MC184 ................
Detectabuse Custom Liquid Control Urine, MC180 ................
Liquichek Immunoassay Plus Control Trilevel MiniPak ...........
Liquichek Immunoassay Plus Control Level 1,2 and 3,
Trilevel.
Liquid Assayed Multiqual Premium, Levels 1–3 ......................
Liquid Assayed Multiqual Premium, Trilevel Minipak ..............
Lyphocheck Urine Toxicology Control MiniPak, Cat. No.
470X.
Liquichek Immunoassay Plus Control Level 1 .........................
2/20/2013
Bio-Rad Laboratories ..............
Liquichek Immunoassay Plus Control Level 2 .........................
Bio-Rad Laboratories ..............
Liquichek Immunoassay Plus Control Level 3 .........................
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Cerilliant
Benzodiazepine Mix (1 mg/mL) ...............................................
Class C Mix Urinalysis Internal Standard Fortified Morphine ..
Spice Cannabinoid Mix 2 (0.1 mg/mL) ....................................
Spice Cannabinoid Mix 3 (0.1 mg/mL) ....................................
Retigabine (1 mg/mL) ..............................................................
±-Norpseudoephedrine-D3 HCl (0.1 mg/mL) ...........................
Amobarbital-D5 (0.1 mg/mL) ....................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine HCl (2C–T–7
HCl) (1 mg/mL).
Class B Mix Urinalysis Internal Standard-8 (0.002–0.2 mg/
mL), Pregabalin-D6 (1.0 mg/mL), Codeine-6-betaglucoronide (1.0 mg/mL), Desomorphine (1.0 mg/mL),
Levorphanol-D3 (0.1 mg/mL).
Zaleplon-D4 (0.1 mg/mL) .........................................................
Retigabine-D4 (0.1 mg/mL) ......................................................
Tilidine-D6 HCl (0.1 mg/mL) ....................................................
TDM Control, Levels 1–3 .........................................................
ELI Oral Fluid Controls, THC (0.5–50 ng/mL) .........................
ELI Oral Fluid Controls, Methamphetamine (2–200 ng/mL) ....
ELI Oral Fluid Controls, Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2–200 ng/mL).
ELI Oral Fluid Controls, Multidrug (THC, Benzoylecgonine,
Amphetamine, Methamphetamine, Morphine, Codeine, 6Acetylmorphine, & PCP) at 0.5–50 ng/mL.
ELI Oral Fluid Calibrators, THC (0.5–50 ng/mL) .....................
ELI Oral Fluid Calibrators, Methamphetamine (2–200 ng/mL)
Glass vial: 2.5 mL, Box 12
vials.
Glass vial: 2.5 mL, Box 12
vials.
Glass vial: 2.5 mL, Box 12
vials.
Glass Ampule: 1 mL ...............
Glass Ampule: 1 mL ...............
Amber ampule: 1 mL ..............
Amber ampule: 1 mL ..............
Glass Ampule: 1 mL ...............
Glass Ampule: 1 mL ...............
Glass Ampule: 1 mL ...............
Glass Ampule: 1 mL ...............
7/2/2012
7/9/2012
9/26/2012
9/26/2012
11/7/2012
1/7/2013
1/7/2013
1/7/2013
Glass ampule: 1 ml .................
1/22/2013
Glass Ampule: 1 mL ...............
Glass ampule: 1ml ..................
Glass ampule: 1ml ..................
Dropper bottle: 5 mL ...............
Glass vial: 5 ml–4 L ................
Glass vial: 5 ml–4 L ................
Glass vial: 5 ml–4 L ................
1/31/2013
3/22/2013
3/22/2013
12/4/2012
10/22/2012
10/22/2012
10/22/2012
Glass vial: 5 ml–4 L ................
10/22/2012
Glass vial: 5 ml–4 L ................
Glass vial: 5 ml–4 L ................
10/22/2012
10/22/2012
Bio-Rad Laboratories ..............
Bio-Rad Laboratories ..............
Bio-Rad Laboratories ..............
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
Corporation
...............
...............
...............
...............
...............
...............
...............
...............
emcdonald on DSK67QTVN1PROD with NOTICES
Cerilliant Corporation ...............
Cerilliant Corporation ...............
Cerilliant Corporation ...............
Cerilliant Corporation ...............
Cliniqa Corporation ..................
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
E:\FR\FM\03JYN1.SGM
03JYN1
2/20/2013
2/20/2013
40178
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
CHART I—Continued
Application
date
Supplier
Product name
Form
ElSohly Laboratories, Inc ........
ELI Oral Fluid Calibrators, Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2–200 ng/mL).
ELI Oral Fluid Calibrators, Multidrug (THC, Benzoylecgonine,
Amphetamine, Methamphetamine, Morphine, Codeine, 6Acetylmorphine, & PCP) at 0.5–200 ng/mL.
USGS–BQS LS 4434 Mix 1 .....................................................
Glass vial: 5 ml–4 L ................
10/22/2012
Glass vial: 5 ml–4 L ................
10/22/2012
Glass Ampule: 2 mL ...............
8/9/2012
USGS–BQS LS 4434 Mix 2 .....................................................
Glass Ampule: 2 mL ...............
8/9/2012
Tapentadol Calibrator Level 1 (100 ng/mL) .............................
Tapentadol Calibrator Level 2 (200 ng/mL) .............................
Tapentadol Calibrator Level 3 (500 ng/mL) .............................
Tapentadol Calibrator Level 4 (1,000 ng/mL) ..........................
Tapentadol Low Control (150 ng/mL) ......................................
Tapentadol High Control (250 ng/mL) .....................................
(S)-(+)-Amphetamine (Dextroamphetamine) 1.0 mg/mL in
Methanol.
rac-Amphetamine 0.1 mg/mL in Methanol ...............................
rac-Amphetamine 1.0 mg/mL in Methanol ...............................
rac-Amphetamine-D11 0.1 mg/mL in Methanol .......................
rac-Amphetamine-D11 1.0 mg/mL in Methanol .......................
rac-Amphetamine-D5 (D-label on ring) 0.1 mg/mL in Methanol.
Methamphetamine ((S)-(+)-Methamphetamine) 1.0 mg/mL in
Methanol.
rac-Methamphetamine 0.1 mg/mL in Methanol .......................
rac-Methamphetamine 1.0 mg/mL in Methanol .......................
rac-Methamphetamine-D5 0.1 mg/mL in Methanol .................
rac-Methamphetamine-D5 1.0 mg/mL in Methanol .................
Methcathinone Hydrochloride 1.0 mg/mL in Methanol (as free
base).
Methylphenidate Hydrochloride 1.0 mg/mL in Methanol (as
free base).
Amobarbital 1.0 mg/mL in Methanol ........................................
Pentobarbital 1.0 mg/mL in Methanol ......................................
Pentobarbital-D5 1.0 mg/mL in Methanol ................................
Pentobarbital-D5 0.1 mg/mL in Methanol ................................
Secobarbital 1.0 mg/mL in Methanol .......................................
rac-MDA–D5 (rac-3,4-Methylenedioxyamphetamine-D5) 0.1
mg/mL Methanol.
rac-MDA–D5 (rac-3,4-Methylenedioxyamphetamine-D5) 1.0
mg/mL Methanol.
rac-MBDB HCl (rac-N-Methyl-1-(3,4-Methylenedioxyphenyl)2-butanamine Hydrochloride) 1.0 mg/mL Methanol (as free
base).
rac-MBDB–D5 (rac-N-Methyl-1-(3,4-Methylenedioxyphenyl)-2butanamine-D5) 0.1 mg/mL Methanol.
rac-MDEA–D5 (rac-3,4-Methylenedioxy-N-ethylamphetamineD5) 0.1 mg/mL Methanol.
rac-MDEA–D5 (rac-3,4-Methylenedioxy-N-ethylamphetamineD5) 1.0 mg/mL Methanol.
rac-MDEA–D6 (rac-3,4-Methylenedioxy-N-ethylamphetamineD6) 0.1 mg/mL Methanol.
rac-MDMA–D5
(rac-3,4-MethylenedioxymethamphetamineD5) 0.1 mg/mL Methanol.
rac-MDMA–D5
(rac-3,4-MethylenedioxymethamphetamineD5) 1.0 mg/mL Methanol.
Phencyclidine (PCP) 1.0 mg/mL Methanol ..............................
Phencyclidine-D5 (PCP-D5) 0.1 mg/mL in Methanol ..............
Phencyclidine-D5 (PCP-D5) 1.0 mg/mL Methanol ..................
Codeine 0.1 mg/mL in Methanol ..............................................
Codeine 1.0 mg/mL in Methanol ..............................................
Codeine-D3 0.1 mg/mL in Methanol ........................................
Codeine-D3 1.0 mg/mL in Methanol ........................................
Codeine-D6 0.1 mg/mL in Methanol ........................................
Codeine-D6 1.0 mg/mL in Methanol ........................................
Isocodeine 0.1 mg/mL in Methanol ..........................................
Norcodeine 0.01 mg/mL in Methanol .......................................
Norcodeine 1.0 mg/mL in Methanol .........................................
Codeine N-Oxide 0.01 mg/mL Methanol .................................
Oxycodone-D3 1.0 mg/mL in Methanol ...................................
Glass
Glass
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
vial:
vial:
10 mL ....................
10 mL ....................
10 mL ....................
10 mL ....................
10 mL ....................
10 mL ....................
1 mL ......................
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
ElSohly Laboratories, Inc ........
Environmental Resource Associates (ERA).
Environmental Resource Associates (ERA).
Immunalysis Corporation .........
Immunalysis Corporation .........
Immunalysis Corporation .........
Immunalysis Corporation .........
Immunalysis Corporation .........
Immunalysis Corporation .........
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
emcdonald on DSK67QTVN1PROD with NOTICES
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
VerDate Mar<15>2010
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
17:48 Jul 02, 2013
Jkt 229001
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
......................
......................
......................
......................
......................
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
......................
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
E:\FR\FM\03JYN1.SGM
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
mL
mL
mL
mL
mL
12/11/2012
12/11/2012
12/11/2012
12/11/2012
12/11/2012
12/11/2012
9/24/2012
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
03JYN1
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
40179
CHART I—Continued
Supplier
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
............................
............................
............................
............................
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
emcdonald on DSK67QTVN1PROD with NOTICES
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
VerDate Mar<15>2010
............................
............................
............................
............................
............................
............................
............................
17:48 Jul 02, 2013
Product name
Form
Oxycodone-D6 0.1 mg/mL in Methanol ...................................
Oxycodone-D6 1.0 mg/mL in Methanol ...................................
Hydromorphone 1.0 mg/mL Methanol .....................................
Norhydromorphone Hydrochloride 1.0 mg/mL Methanol (as
free base).
Pethidine (Meperidine) 1.0 mg/mL in Methanol .......................
Pethidine-D4 (Meperidine-D4) 0.1 mg/mL in Methanol ...........
Pethidine-D4 (Meperidine-D4) 1.0 mg/mL in Methanol ...........
Morphine 0.1 mg/mL in Methanol ............................................
Morphine 1.0 mg/mL in Methanol ............................................
Morphine 3-beta-D-Glucuronide 0.1 mg/mL in Methanol/
Water (1⁄1).
Morphine 3-beta-D-Glucuronide 1.0 mg/mL in Methanol with
0.05 percent Sodium Hydroxide (w/v).
Morphine 6-beta-D-Glucuronide 0.1 mg/mL in Methanol/
Water (1⁄1).
Morphine 6-beta-D-Glucuronide 1.0 mg/mL Water/Methanol
(80/20).
Morphine-D3 0.1 mg/mL in Methanol ......................................
Morphine-D3 1.0 mg/mL in Methanol ......................................
Morphine N-Oxide 0.01 mg/mL Methanol ................................
Normorphine 1.0 mg/mL Methanol ..........................................
rac-Amphetamine-D10 0.1 mg/mL in Methanol .......................
rac-Amphetamine-D5 (D-label on ring) 0.1 mg/mL in Methanol.
rac-Amphetamine-D5 (D-label on side chain) 0.1 mg/mL in
Methanol.
rac-Amphetamine-D5 (D-label on side chain) 1.0 mg/mL in
Methanol.
rac-Amphetamine-D6 0.1 mg/mL in Methanol .........................
rac-Amphetamine-D6 1.0 mg/mL in Methanol .........................
rac-Amphetamine-D8 0.1 mg/mL in Methanol .........................
rac-Amphetamine-D8 1.0 mg/mL in Methanol .........................
rac-Methamphetamine-D11 0.1 mg/mL in Methanol ...............
rac-Methamphetamine-D11 1.0 mg/mL in Methanol ...............
rac-Methamphetamine-D14 0.1 mg/mL in Methanol ...............
rac-Methamphetamine-D14 1.0 mg/mL in Methanol ...............
rac-Methamphetamine-D8 0.1 mg/mL in Methanol .................
rac-Methamphetamine-D8 1.0 mg/mL in Methanol .................
rac-Methamphetamine-D9 0.1 mg/mL in Methanol .................
rac-Methamphetamine-D9 1.0 mg/mL in Methanol .................
(+)-Norpseudoephedrine Hydrochloride (Cathine Hydrochloride) 0.1 mg/mL in Methanol (as free base).
(R)-(+)-Cathinone Hydrochloride 1.0 mg/mL in Methanol (as
free base).
(S)-(-)-Cathinone Hydrochloride 1.0 mg/mL in Methanol (as
free base).
(S)-(-)-Methcathinone Hydrochloride 1.0 mg/mL in Methanol
(as free base).
Phentermine 1.0 mg/mL in Methanol .......................................
Fenfluramine Hydrochloride 1.0 mg/mL in Methanol (as free
base).
Methylphenidate-D9 Hydrochloride 0.1 mg/mL in Methanol ...
Pipradrol Hydrochloride 0.1 mg/mL in Methanol (as free
base).
Pipradrol Hydrochloride 1.0 mg/mL in Methanol (as free
base).
GHB Sodium Salt (Sodium Gammahydroxybutyrate) 1.0 mg/
mL in Methanol (as free acid).
GHB–D6 Sodium Salt (Sodium Gammahydroxybutyrate-D6)
0.1 mg/mL in Methanol (as free acid).
GHB–D6 Sodium Salt (Sodium Gammahydroxybutyrate-D6)
1.0 mg/mL in Methanol (as free acid).
Hexobarbital 1.0 mg/mL in Methanol .......................................
Methohexital 1.0 mg/mL in Methanol .......................................
Methohexital-D5 0.1 mg/mL in Methanol .................................
Phenobarbital 1.0 mg/mL in Methanol .....................................
Phenobarbital-D5 (D-label on ring) 0.1 mg/mL in Methanol ....
Phenobarbital-D5 (D-label on ring) 1.0 mg/mL in Methanol ....
Phenobarbital-D5 (D-label on side chain) 0.1 mg/mL in Methanol.
Jkt 229001
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Application
date
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
1
1
1
1
mL
mL
mL
mL
......................
......................
......................
......................
9/24/2012
9/24/2012
9/24/2012
9/24/2012
Glass
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
......................
......................
......................
......................
......................
......................
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass vial: 1 mL ......................
9/24/2012
Glass
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
......................
9/24/2012
9/24/2012
9/24/2012
9/24/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
E:\FR\FM\03JYN1.SGM
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
03JYN1
......................
......................
......................
......................
......................
......................
......................
40180
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
CHART I—Continued
Application
date
Supplier
Product name
Form
LGC Limited ............................
Phenobarbital-D5 (D-label on side chain) 1.0 mg/mL in Methanol.
Methaqualone 1.0 mg/mL in Methanol ....................................
Methaqualone-D7 0.1 mg/mL in Methanol ..............................
Clonazepam 1.0 mg/mL in Methanol .......................................
Clonazepam-D4 0.1 mg/mL in Methanol .................................
Chlordiazepoxide 1.0 mg/mL in Methanol ...............................
Chlordiazepoxide-D5 0.1 mg/mL in Methanol .........................
Bromazepam 0.1 mg/mL in Methanol ......................................
Bromazepam 1.0 mg/mL in Methanol ......................................
Clobazam 1.0 mg/mL in Methanol ...........................................
Delorazepam 0.1 mg/mL in Methanol ......................................
Estazolam 1.0 mg/mL in Methanol ..........................................
Estazolam-D5 0.1 mg/mL in Methanol ....................................
Flunitrazepam 0.1 mg/mL in Methanol ....................................
Flunitrazepam 1.0 mg/mL in Methanol ....................................
Flunitrazepam-D7 0.1 mg/mL in Methanol ..............................
Prazepam 1.0 mg/mL in Methanol ...........................................
Prazepam-D5 0.1 mg/mL in Methanol .....................................
Diazepam 0.1 mg/mL in Methanol ...........................................
Diazepam 1.0 mg/mL in Methanol ...........................................
Diazepam-D5 0.1 mg/mL in Methanol .....................................
Diazepam-D5 1.0 mg/mL in Methanol .....................................
Flurazepam 0.1 mg/mL in Methanol ........................................
Flurazepam 1.0 mg/mL in Methanol ........................................
Lormetazepam 1.0 mg/mL in Methanol ...................................
Zaleplon 1.0 mg/mL in Methanol .............................................
Pregabalin 1.0 mg/mL in Methanol ..........................................
Pregabalin-D6 0.1 mg/mL in Methanol ....................................
Zolpidem Tartrate 1.0 mg/mL in Methanol (as free base) .......
Zolpidem-D6 0.1 mg/mL in Methanol ......................................
Zopiclone 1.0 mg/mL in Acetonitrile ........................................
Zopiclone Oxide 1.0 mg/mL in Methanol .................................
Zopiclone-D4 0.1 mg/mL in Acetonitrile ...................................
Meprobamate 1.0 mg/mL in Methanol .....................................
Nitrazepam 0.1 mg/mL in Acetonitrile ......................................
Nitrazepam 1.0 mg/mL in Acetonitrile ......................................
Nitrazepam-D5 0.1 mg/mL in Acetonitrile ................................
Oxazepam 1.0 mg/mL in Methanol ..........................................
Oxazepam-D5 0.1 mg/mL in Methanol ....................................
Oxazepam-D5 1.0 mg/mL in Methanol ....................................
Nordazepam (Nordiazepam) 0.1 mg/mL in Methanol .............
Nordazepam (Nordiazepam) 1.0 mg/mL in Methanol .............
Nordazepam-D5 (Nordiazepam-D5) 0.1 mg/mL in Methanol ..
Nordazepam-D5 (Nordiazepam-D5) 1.0 mg/mL in Methanol ..
Alprazolam 1.0 mg/mL in Methanol .........................................
Alprazolam-D5 0.1 mg/mL in Methanol ...................................
Alprazolam-D5 1.0 mg/mL in Methanol ...................................
Methyltestosterone (17alpha-Methyltestosterone) 1.0 mg/mL
in Acetonitrile.
Midazolam 1.0 mg/mL in Methanol ..........................................
Midazolam-D4 Maleate 0.1 mg/mL in Methanol (as free
base).
Lorazepam 0.1 mg/mL in Acetonitrile ......................................
Lorazepam 1.0 mg/mL in Acetonitrile ......................................
Lorazepam Acetate ((3RS)-7-Chloro-5-(2-chlorophenyl)-2oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl Acetate) 0.1
mg/mL in Acetonitrile.
Lorazepam-D4 0.1 mg/mL in Acetonitrile ................................
Lorazepam-D4 1.0 mg/mL in Acetonitrile ................................
Tetrazepam 0.1 mg/mL in Methanol ........................................
Triazolam 1.0 mg/mL in Methanol ...........................................
Triazolam-D4 0.1 mg/mL in Methanol .....................................
Temazepam 0.1 mg/mL in Methanol .......................................
Temazepam 1.0 mg/mL in Methanol .......................................
Temazepam-D5 0.1 mg/mL in Methanol .................................
Temazepam-D5 1.0 mg/mL in Methanol .................................
Androstanolone (5alpha-Dihydrotestosterone, Stanolone) 1.0
mg/mL in Acetonitrile.
Androstenedione (Androst-4-ene-3, 17-dione) 1.0 mg/mL in
Acetonitrile.
Glass vial: 1 mL ......................
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
emcdonald on DSK67QTVN1PROD with NOTICES
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
LGC Limited ............................
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
E:\FR\FM\03JYN1.SGM
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
03JYN1
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
40181
CHART I—Continued
Supplier
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
............................
............................
............................
............................
emcdonald on DSK67QTVN1PROD with NOTICES
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
VerDate Mar<15>2010
17:48 Jul 02, 2013
Product name
Form
Boldenone 1.0 mg/mL in Acetonitrile .......................................
Fluoxymesterone 1.0 mg/mL in Acetonitrile ............................
Mesterolone 1.0 mg/mL in Acetonitrile ....................................
Methandienone 1.0 mg/mL in Acetonitrile ...............................
Nandrolone 1.0 mg/mL in Acetonitrile .....................................
Norandrostenedione (19-Norandrost-4-ene-3,17-dione) 1.0
mg/mL in Acetonitrile.
Norethandrolone 1.0 mg/mL in Acetonitrile .............................
Stanozolol 1.0 mg/mL in Acetonitrile .......................................
Stanozolol-D3 0.1 mg/mL in 1,2-Dimethoxyethane .................
Testosterone 1.0 mg/mL in Acetonitrile ...................................
Testosterone Benzoate 1.0 mg/mL in Acetonitrile ...................
Testosterone Isocaproate 1.0 mg/mL in Acetonitrile ...............
Testosterone Propionate 1.0 mg/mL in Acetonitrile ................
Trenbolone 1.0 mg/mL in Acetonitrile ......................................
RCS–4
(DD–001,
(4-Methoxyphenyl)(1-pentylindol-3yl)methanone) 1.0 mg/mL in Acetonitrile.
JWH–081
((4-Methoxynaphthalen-1-yl)(1-pentylindol-3yl)methanone) 1.0 mg/mL in Acetonitrile.
JWH–122
((4-Methylnaphthalen-1-yl)(1-pentylindol-3yl)methanone) 1.0 mg/mL in Acetonitrile.
JWH–203 (2-(2-Chlorophenyl)-1-(1-pentylindol-3-yl)ethanone)
1.0 mg/mL in Acetonitrile.
Ketamine Hydrochloride 1.0 mg/mL in Methanol (as free
base).
Ketamine-D4 Hydrochloride 0.1 mg/mL in Methanol (as free
base).
Iso-LSD (Lysergic Acid Diethylamide) 0.1 mg/mL in Acetonitrile.
LAMPA (Lysergic Acid N-Methyl-N-propylamide) 0.025 mg/
mL in Acetonitrile.
LSD (Lysergic Acid Diethylamide) 0.025 mg/mL in Acetonitrile.
LSD–D3 (Lysergic Acid Diethylamide-D3) 0.025 mg/mL in
Acetonitrile.
PMA HCl (p-Methoxyamphetamine) 1.0 mg/mL in Methanol
(as free base).
rac-MDA (rac-3,4-Methylenedioxyamphetamine) 1.0 mg/mL
in Methanol.
rac-MDEA (rac-3,4-Methylenedioxy-N-ethylamphetamine) 1.0
mg/mL in Methanol.
1-Methylamino-1-(3,4-methylenedioxyphenyl)propane Hydrochloride 1.0 mg/mL in Methanol (as free base).
rac-BDB HCl (rac-3,4-Methylenedioxyphenyl-2-butanamine
Hydrochloride) 1.0 mg/mL in Methanol (as free base).
rac-MDMA (rac-3,4-Methylenedioxymethamphetamine) 1.0
mg/mL in Methanol.
Bufotenine 1.0 mg/mL in Acetonitrile .......................................
Methylone Hydrochloride 1.0 mg/mL in Methanol (as free
base).
Methylone-D3 Hydrochloride 0.1 mg/mL in Methanol (as free
base).
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole) 1.0 mg/
mL in Acetonitrile.
Cocaine 1.0 mg/mL in Acetonitrile ...........................................
Cocaine-D3 0.1 mg/mL in Acetonitrile .....................................
Cocaine-D3 1.0 mg/mL in Acetonitrile .....................................
Norcocaine Hydrochloride 1.0 mg/mL in Acetonitrile (as free
base).
Norcocaine-D3 Hydrochloride 0.1 mg/mL in Acetonitrile (as
free base).
O-Methylcodeine 0.1 mg/mL in Acetonitrile .............................
Buprenorphine 0.1 mg/mL in Methanol ...................................
Buprenorphine 3-beta-D-Glucuronide 0.1 mg/mL in Methanol
Buprenorphine-D4 0.1 mg/mL in Methanol ..............................
Dihydrocodeine Hydrochloride 1.0 mg/mL in Methanol (as
free base).
Dihydrocodeine-D6 Hydrochloride 0.1 mg/mL in Methanol (as
free base).
Noroxycodone Hydrochloride 1.0 mg/mL in Methanol (as free
base).
Jkt 229001
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
Application
date
Glass
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
mL
mL
mL
......................
......................
......................
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass
Glass
Glass
Glass
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
E:\FR\FM\03JYN1.SGM
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
mL
mL
mL
03JYN1
40182
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
CHART I—Continued
Application
date
Supplier
Product name
Form
LGC Limited ............................
Noroxycodone-D3 Hydrochloride 0.1 mg/mL in Methanol (as
free base).
Oxycodone 1.0 mg/mL in Methanol .........................................
Oxycodone-D3 0.1 mg/mL in Methanol ...................................
Dihydromorphine 1.0 mg/mL in Methanol ................................
Hydromorphone-D3 0.1 mg/mL in Methanol ...........................
Anhydroecgonine Hydrochloride 1.0 mg/mL in Acetonitrile (as
free base).
Anhydroecgonine Methyl Ester 1.0 mg/mL in Acetonitrile .......
Benzoylecgonine 0.1 mg/mL in Methanol ................................
Benzoylecgonine-D3 0.1 mg/mL in Methanol ..........................
Benzoylecgonine-D3 1.0 mg/mL in Methanol ..........................
Benzoylecgonine-D8 0.1 mg/mL in Methanol ..........................
Benzoylecgonine-D8 1.0 mg/mL in Methanol ..........................
Cocaethylene (Benzoylethylecgonine) 1.0 mg/mL in Acetonitrile.
Cocaethylene-D3 (Benzoylethylecgonine-D3) 0.1 mg/mL in
Acetonitrile.
Cocaethylene-D8 (Benzoylethylecgonine-D8) 0.1 mg/mL in
Acetonitrile.
Ecgonine 1.0 mg/mL in Methanol ............................................
Ecgonine Ethyl Ester 1.0 mg/mL in Acetonitrile ......................
Ecgonine Hydrochloride 1.0 mg/mL in Methanol (as free
base).
Ecgonine Methyl Ester 0.1 mg/mL in Acetonitrile ....................
Ecgonine Methyl Ester 1.0 mg/mL in Acetonitrile ....................
Ecgonine-D3 Hydrochloride 0.1 mg/mL in Methanol (as free
base).
Ecgonine-D3 Methyl Ester 0.1 mg/mL in Acetonitrile ..............
Ethylmorphine 1.0 mg/mL in Methanol ....................................
Hydrocodone 1.0 mg/mL in Methanol ......................................
Hydrocodone-D3 0.1 mg/mL in Methanol ................................
Hydrocodone-D6 0.1 mg/mL in Methanol ................................
Norhydrocodone Hydrochloride 1.0 mg/mL in Methanol (as
free base).
Heroin (Diacetylmorphine) 1.0 mg/mL in Acetonitrile ..............
Heroin-D9 (Diacetylmorphine-D9) 0.1 mg/mL in Acetonitrile ..
Heroin-D9 (Diacetylmorphine-D9) 1.0 mg/mL in Acetonitrile ..
rac-Methadone 0.1 mg/mL in Methanol ...................................
rac-Methadone 1.0 mg/mL in Methanol ...................................
rac-Methadone-D3 0.1 mg/mL in Methanol .............................
rac-Methadone-D3 1.0 mg/mL in Methanol .............................
rac-Methadone-D9 0.1 mg/mL in Methanol .............................
rac-Methadone-D9 1.0 mg/mL in Methanol .............................
Dextropropoxyphene 0.1 mg/mL in Acetonitrile .......................
Dextropropoxyphene 1.0 mg/mL in Acetonitrile .......................
rac-Propoxyphene-D11 0.1 mg/mL in Acetonitrile ...................
rac-Propoxyphene-D11 1.0 mg/mL in Acetonitrile ...................
rac-Propoxyphene-D5 0.1 mg/mL in Acetonitrile .....................
rac-Propoxyphene-D5 1.0 mg/mL in Acetonitrile .....................
6-Acetylmorphine 0.1 mg/mL in Acetonitrile ............................
6-Acetylmorphine 1.0 mg/mL in Acetonitrile ............................
6-Acetylmorphine-D3 0.1 mg/mL in Acetonitrile ......................
6-Acetylmorphine-D3 1.0 mg/mL in Acetonitrile ......................
6-Acetylmorphine-D6 0.1 mg/mL in Acetonitrile ......................
6-Acetylmorphine-D6 1.0 mg/mL in Acetonitrile ......................
Acetylcodeine 0.1 mg/mL in Acetonitrile ..................................
Acetylcodeine 1.0 mg/mL in Acetonitrile ..................................
Nordihydromorphine Hydrochloride 1.0 mg/mL in Methanol
(as free base).
Oxymorphone 1.0 mg/mL in Methanol ....................................
Oxymorphone-D3 0.1 mg/mL in Methanol ...............................
Oxymorphone-D3 1.0 mg/mL in Methanol ...............................
Noroxymorphone Hydrochloride 0.1 mg/mL in Methanol (as
free base).
Noroxymorphone Hydrochloride 1.0 mg/mL in Methanol (as
free base).
Butorphanol Tartrate 1.0 mg/mL in Methanol (as free base) ..
Sufentanil Citrate 0.1 mg/mL in Methanol (as free base) .......
Glass vial: 1 mL ......................
11/30/2012
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
mL
mL
mL
mL
mL
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
mL
......................
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
mL
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass
Glass
Glass
Glass
vial:
vial:
vial:
vial:
1
1
1
1
mL
mL
mL
mL
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
LGC
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
LGC
emcdonald on DSK67QTVN1PROD with NOTICES
LGC
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
............................
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
E:\FR\FM\03JYN1.SGM
03JYN1
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
40183
CHART I—Continued
Application
date
Supplier
Product name
Form
LGC Limited ............................
cis-Tilidine
(Ethyl
(1R,2RS)-2-(Dimethylamino)-1phenylcyclohex-3-enecarboxylate) 0.1 mg/mL in Acetonitrile.
Tilidine 0.1 mg/mL in Acetonitrile .............................................
Abbott TDM Multiconstituent Calibrator (CAL 1–6) Catalog
Number: 5P04–01.
Thermo Scientific DRI Opiate Assay Catalog Number:
100014602.
Thermo Scientific DRI Cannabinoid Assay Catalog Number:
10014665.
Thermo Scientific Phencyclidine Assay Catalog Number:
10014673.
Thermo Scientific Ecstacy Assay Catalog Number: 10014681
Thermo Scientific CEDIA Methamphetamine OFT Calibrator
1: Catalog Number 10016362.
Thermo Scientific CEDIA Methamphetamine OFT Calibrator
2: Catalog Number 10063.
Thermo Scientific CEDIA Methamphetamine OFT Calibrator
3: Catalog Number 10016364.
Thermo Scientific CEDIA Methamphetamine OFT Control 1:
Catalog Number 10017686.
Thermo Scientific CEDIA Methamphetamine OFT Control 2:
Catalog Number 10017687.
Thermo Scientific CEDIA Methamphetamine OFT Control 3:
Catalog Number 1007688.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 1: Catalog Number 10016882.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 2: Catalog Number 10016883.
Thermo Scientific CEDIA Multi-Drug OFT Calibrator 3: Catalog Number 10016884.
Thermo Scientific CEDIA Multi-Drug OFT Control 1: Catalog
Number 10017711.
Thermo Scientific CEDIA Multi-Drug OFT Control 2: Catalog
Number 10017712.
Thermo Scientific CEDIA Multi-Drug OFT Control 3: Catalog
Number 10017713.
Thermo Scientific CEDIA THC OFT Calibrator 1: Catalog
Number 10016700.
Thermo Scientific CEDIA THC OFT Calibrator 2: Catalog
Number 10016701.
Thermo Scientific CEDIA THC OFT Calibrator 3: Catalog
Number 10016702.
Thermo Scientific CEDIA THC OFT Control 1: Catalog Number 10017702.
Thermo Scientific CEDIA THC OFT Control 2: Catalog Number 10017703.
Thermo Scientific CEDIA THC OFT Control 3: Catalog Number 10017704.
VITROS Immunodiagnostics Products Testosterone Reagent
Pack.
VITROS Immunodiagnostics Products Estradiol Reagent
Pack.
VITROS Immunodiagnostics Products Testosterone Calibrators (1–3).
VITROS Immunodiagnostics Products Testosterone Controls
(1–3).
VITROS Immunodiagnostics Products Testosterone Range
Verifiers (Low and High).
Custom Revised Appendix IX Mix #1 ......................................
Product and Reactor Samples Standard .................................
8270 Supplemental Standard #1 .............................................
TTST Stock X (Bulk) ................................................................
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Box: 7 vials; 5 mL each ..........
11/30/2012
7/2/2012
Vial: 18 mL, Box: 3 vials .........
1/30/2013
Vial: 18 mL, Box: 3 vials .........
1/30/2013
Vial: 18 mL, Box: 3 vials .........
1/30/2013
Vial: 18 mL, Box: 3 vials .........
Vial: 5 mL; Box: 1 vial ............
1/30/2013
2/11/2013
Vial: 5 mL; Box: 1 vial ............
2/11/2013
Vial: 5 mL; Box: 1 vial ............
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 15 mL; Box: 1 vial ..........
2/11/2013
Vial: 15 mL; Box: 1 vial ..........
2/11/2013
Vial: 15 mL; Box: 1 vial ..........
2/11/2013
Vial: 5 mL; Box: 1 vial ............
2/11/2013
Vial: 5 mL; Box: 1 vial ............
2/11/2013
Vial: 5 mL; Box: 1 vial ............
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Vial: 10 mL; Box: 1 vial ..........
2/11/2013
Plastic chamber: 8.4 mL .........
9/28/2012
Plastic chamber: 13.3 mL .......
9/28/2012
Box: 3 vials; 2 mL each ..........
10/19/2012
Box: 9 vials; 1 mL each ..........
10/19/2012
Box: 4 vials; 1–1.5 mL each ...
10/19/2012
Glass vial: 1.3 mL ...................
Ampule: 2 mL .........................
Ampule: 2 mL .........................
Stock container: 50 mL–1 L ...
2/14/2013
10/12/2012
12/13/2012
7/26/2012
VS TTST Cal Bulk Soln Level 1 ..............................................
Bulk container: 4 mL–100 L ...
7/26/2012
VS TTST Cal Bulk Soln Level 2 ..............................................
Bulk container: 4 mL–100 L ...
7/26/2012
VS TTST Cal Bulk Soln Level 3 ..............................................
Bulk container: 4 mL–100 L ...
7/26/2012
LGC Limited ............................
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Microgenics Corporation .........
Ortho Clinical Diagnostics, Inc
Ortho Clinical Diagnostics, Inc
Ortho Clinical Diagnostics, Inc
Ortho Clinical Diagnostics, Inc
emcdonald on DSK67QTVN1PROD with NOTICES
Ortho Clinical Diagnostics, Inc
Restek .....................................
Restek Corporation .................
Restek Corporation .................
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
E:\FR\FM\03JYN1.SGM
03JYN1
40184
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
CHART I—Continued
Application
date
Product name
Form
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Siemens Healthcare
Diagnostics Inc.
Supelco, Inc .............................
emcdonald on DSK67QTVN1PROD with NOTICES
Supplier
VS TTST Cal Bulk Soln Level 4 ..............................................
Bulk container: 4 mL–100 L ...
7/26/2012
VS TTST Cal Bulk Soln Level 5 ..............................................
Bulk container: 4 mL–100 L ...
7/26/2012
VS TTST Cal Bulk Soln Level 6 ..............................................
Bulk container: 4 mL–100 L ...
7/26/2012
Dimension Vista TTST CAL A .................................................
Vial: 1 mL ................................
7/26/2012
Dimension Vista TTST CAL B .................................................
Vial: 1 mL ................................
7/26/2012
Dimension Vista TTST CAL C .................................................
Vial: 1 mL ................................
7/26/2012
Dimension Vista TTST CAL D .................................................
Vial: 1 mL ................................
7/26/2012
Dimension Vista TTST CAL E .................................................
Vial: 1 mL ................................
7/26/2012
Dimension Vista TTST CAL F .................................................
Vial: 1 mL ................................
7/26/2012
Dimension Vista System TTST CAL ........................................
Box: 12 vials; 1 ml each .........
7/26/2012
MP TTST Lvl 1 Bulk .................................................................
Bulk container: 4 mL–20 L .....
7/26/2012
MP TTST Lvl 2 Bulk .................................................................
Bulk container: 4 mL–20 L .....
7/26/2012
MP TTST Lvl 3 Bulk .................................................................
Bulk container: 4 mL–20 L .....
7/26/2012
MP TTST Lvl 4 Bulk .................................................................
Bulk container: 4 mL–20 L .....
7/26/2012
MP TTST Lvl 5 Bulk .................................................................
Bulk container: 4 mL–20 L .....
7/26/2012
MP TTST Lvl 6 Bulk .................................................................
Bulk container: 4 mL–20 L .....
7/26/2012
MP TTST CAL Lvl 1 FC ...........................................................
Vial: 1–5 mL ............................
7/26/2012
MP TTST CAL Lvl 2 FC ...........................................................
Vial: 1–5 mL ............................
7/26/2012
MP TTST CAL Lvl 3 FC ...........................................................
Vial: 1–5 mL ............................
7/26/2012
MP TTST CAL Lvl 4 FC ...........................................................
Vial: 1–5 mL ............................
7/26/2012
MP TTST CAL Lvl 5 FC ...........................................................
Vial: 1–5 mL ............................
7/26/2012
MP TTST CAL Lvl 6 FC ...........................................................
Vial: 1–5 mL ............................
7/26/2012
TTST Stock S (Bulk) ................................................................
Stock container: 50 mL–1 L ...
7/26/2012
TTST Stock T (Bulk) ................................................................
Stock container: 50 mL–1 L ...
7/26/2012
Estradiol Diluent .......................................................................
Plastic container: 0.5L–1.0L ...
11/14/2012
Dimension Vista Drug 1 CAL Pilot, Level B ............................
Plastic test tube: 15 mL ..........
12/3/2012
Titan C18 Batch Test 1 Mix .....................................................
Glass ampule: 1 mL ...............
2/28/2013
The Deputy Assistant Administrator
has found that each of the compounds,
mixtures, and preparations described in
Chart II below is not consistent with the
criteria stated in 21 U.S.C. 811(g)(3)(B)
and in 21 CFR 1308.23. Accordingly, the
Deputy Assistant Administrator has
determined that the chemical
preparations or mixtures generally
described in Chart II below and
specifically described in the application
materials received by DEA, are not
exempt from application of any part of
the CSA or from application of any part
of the CFR, with regard to the requested
exemption pursuant to 21 CFR 1308.23,
as of the date listed below that was
provided in the determination letters to
the individual requesters.
CHART II
Supplier
Product name
Form
Agilent Technologies ...............
Forensic Toxicology Comprehensive Mix–Submix 9A ............
Ampule: 1 mL .........................
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
E:\FR\FM\03JYN1.SGM
03JYN1
Application
date
12/6/2012
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
40185
CHART II—Continued
Application
date
Supplier
Product name
Form
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Biochemical Diagnostics, Inc ..
Cerilliant Corporation ...............
Cerilliant Corporation ...............
Cerilliant Corporation ...............
Cliniqa Corporation ..................
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
Detectabuse Custom Liquid Control Urine, MC177 ................
Detectabuse Custom Liquid Control Urine, MC178 ................
Salivabuse Custom Liquid Control Oral Fluid, OF24 ..............
Detectabuse Custom Liquid Control Urine, MC180 ................
Detectabuse Custom Liquid Control Urine, MC181 ................
Detectabuse Custom Liquid Control Urine, MC182 ................
Detectabuse Custom Liquid Control Urine, MC180 ................
Detectabuse Custom Liquid Control Urine, MC182 ................
(-)-11-nor-9-Carboxy-delta9-THC (1 mg/mL) ...........................
Cocaine HCl (10 mg/mL) .........................................................
Lacosamide (10 mg/mL) ..........................................................
TDM Control, Levels 1–3 Bulk .................................................
ELI Oral Fluid Controls, THC (0.5–50 ng/mL) .........................
ELI Oral Fluid Controls, Methamphetamine (2–200 ng/mL) ....
ELI Oral Fluid Controls, Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2–200 ng/mL).
ELI Oral Fluid Controls, Multidrug (selected from THC, Cocaine/Benzoylecgonine, Amphetamines, Opiates, & PCP at
0.5–50 ng/mL).
ELI Oral Fluid Calibrators, THC (0.5–50 ng/mL) .....................
ELI Oral Fluid Calibrators, Methamphetamine (2–200 ng/mL)
ELI Oral Fluid Calibrators, Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2–200 ng/mL).
ELI Oral Fluid Calibrators, Multidrug (selected from THC, Cocaine/Benzoylecgonine, Amphetamines, Opiates, & PCP at
0.5–200 ng/mL).
LAMPA (Lysergic Acid N-Methyl-N-propylamide) 1.0 mg/mL
in Acetonitrile.
LSD (Lysergic Acid Diethylamide) 1.0 mg/mL in Acetonitrile ..
LSD–D3 (Lysergic Acid Diethylamide-D3) 0.1 mg/mL in Acetonitrile.
(-)-Cannabidiol 1.0 mg/mL in Methanol ...................................
Cannabinol 1.0 mg/mL in Methanol .........................................
(-)-delta9-THC (Dronabinol) 1.0 mg/mL in Methanol ...............
(-)-delta9-THC-D3 (Dronabinol-D3) 0.1 mg/mL in Methanol ...
trans-11-Hydroxy-delta9-THC
((6aRS,10aRS)-11-Hydroxydelta9-tetrahydrocannabinol) 0.1 mg/mL in Methanol.
trans-11-Hydroxy-delta9-THC
((6aRS,10aRS)-11-Hydroxydelta9-tetrahydrocannabinol) 1.0 mg/mL in Methanol.
trans-11-Hydroxy-delta9-THC-D3 (trans-11-Hydroxy-delta9tetrahydrocannabinol-D3) 0.1 mg/mL in Methanol.
trans-11-Nor-9-carboxy-delta9-THC 0.1 mg/mL in Methanol ..
trans-11-Nor-9-carboxy-delta9-THC-D3 0.1 mg/mL in Methanol.
trans-11-Nor-9-carboxy-delta9-THC-D3 1.0 mg/mL in Methanol.
Fentanyl 0.1 mg/mL in Methanol .............................................
Fentanyl 1.0 mg/mL in Methanol .............................................
Fentanyl-D5 0.1 mg/mL in Methanol .......................................
Dimension Vista Drug 1 CAL Bulk, Level B ............................
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–2 L ..............
Glass vials: 1 ml–200 mL .......
Glass vials: 1 ml–2 L ..............
Glass ampule: 5 mL ...............
Glass Ampule: 1 mL ...............
Glass Ampule: 1 mL ...............
Plastic Container: 500 L .........
Glass vial: 5 ml–4 L ................
Glass vial: 5 ml–4 L ................
Glass vial: 5 ml–4 L ................
10/11/2012
10/23/2012
10/23/2012
12/14/2012
12/14/2012
1/22/2013
1/29/2013
2/14/2013
7/6/2012
7/6/2012
9/12/2012
12/4/2012
8/9/2012
8/9/2012
8/9/2012
Glass vial: 5 ml–4 L ................
8/9/2012
Glass vial: 5 ml–4 L ................
Glass vial: 5 ml–4 L ................
Glass vial: 5 ml–4 L ................
8/9/2012
8/9/2012
8/9/2012
Glass vial: 5 ml–4 L ................
8/9/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
Glass
Glass
Glass
Glass
Glass
......................
......................
......................
......................
......................
11/30/2012
11/30/2012
11/30/2012
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
11/30/2012
11/30/2012
Glass vial: 1 mL ......................
11/30/2012
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
Glass vial: 1 mL ......................
Plastic container: 4–100 L ......
11/30/2012
11/30/2012
11/30/2012
12/3/2012
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
ElSohly Laboratories, Inc ........
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC
LGC
LGC
LGC
LGC
Limited
Limited
Limited
Limited
Limited
............................
............................
............................
............................
............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
LGC Limited ............................
Siemens Healthcare
Diagnostics Inc.
emcdonald on DSK67QTVN1PROD with NOTICES
Scope of Approval
The exemptions are applicable only to
the precise preparation or mixture
described in the application submitted
to DEA in the form(s) listed in this order
and only for those sections of the CSA
and the CFR that are specifically
identified. Pursuant to 21 CFR
1308.24(h), any change in the
quantitative or qualitative composition
of the preparation or mixture or change
in the trade name or other designation
of the preparation or mixture after the
date of application requires a new
application. Pursuant to 21 CFR
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
1308.24(g), DEA may prescribe
requirements other than those set forth
in 1308.24(b)–(e) on a case-by-case basis
for materials exempted in bulk
quantities. Accordingly, in order to limit
opportunity for diversion from the
larger bulk quantities, DEA has
determined that each of the exempted
bulk products listed in this order may
only be used by the manufacturer and
may not be distributed by the
manufacturer for any purpose or
transported to other facilities.
Additional exempt chemical
preparation requests received between
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
vial:
vial:
vial:
vial:
vial:
1
1
1
1
1
mL
mL
mL
mL
mL
July 1, 2012, and March 31, 2013, and
not otherwise referenced in this order
may remain under consideration until
DEA receives additional information
required, pursuant to 21 CFR
1308.23(d), as detailed in separate
correspondence to individual
requesters. DEA’s order on such
requests will be communicated to the
public in a future Federal Register
publication.
DEA also notes that these exemptions
are limited to exemption from only
those sections of the CSA and the CFR
that are specifically identified in 21 CFR
E:\FR\FM\03JYN1.SGM
03JYN1
40186
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
emcdonald on DSK67QTVN1PROD with NOTICES
1308.24(a). All other requirements of the
CSA and the CFR apply, including, but
not limited to, registration as an
importer as required by 21 U.S.C. 957.
controlled substance will require a new
application for exemption pursuant to
21 U.S.C. 811(g)(3)(B) and 21 CFR
1308.23–1308.24.
Dated: June 17, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Chemical Preparations Containing
Newly Controlled Substances
The statutory authority for exempt
chemical preparations is based on the
control status of substances contained
within a preparation, the intended
administration of a preparation, and the
packaged form of a preparation. DEA
conducts a case-by-case analysis of each
application for exemption to determine
whether exemption of a preparation
from certain provisions of the CSA is
appropriate pursuant to the specified
statutory and regulatory requirements.
Most exempt chemical preparations
have remained effective until the holder
of a specific exempt chemical
preparation specifically requested that
the exemption be terminated. The CSA
allows for modifications to the
controlled substances schedules to add,
remove, or change the schedule of
substances thus resulting in periodic
modifications to the control status of
various substances. 21 U.S.C. 811(a).
Since the CSA was enacted in 1970,
DEA has on several occasions added to,
removed from, or modified the
schedules of controlled substances in
accordance with the CSA. Such changes
may result in the non-compliance of
exempt chemical preparations with
current statutes or regulations if
chemical preparations that have already
obtained exempt status contain newly
controlled substances. For example,
although an exempt chemical
preparation may continue to be
packaged in the same manner as when
it was approved, non-controlled
substances in the preparation may
become controlled, thus prompting the
need for a new application for
exemption of the chemical preparation
to ensure continued compliance. Other
preparations that previously contained
no controlled substances may contain
newly controlled substances and thus
would require an application for
exemption.
DEA reviews applications for
chemical preparation exemptions based
on the statutes and regulations that are
in place at the time of the application,
including the control status of
substances included in the preparation.
DEA must remain vigilant to ensure that
exempt chemical preparations remain
consistent with the standards set forth
in the CSA and its implementing
regulations. As such, DEA reminds the
public that any chemical preparation,
regardless of whether it was previously
exempt, that contains a newly
Review of Exemptions Pursuant to 21
U.S.C. 811(g)(3)
BILLING CODE 4410–09–P
Based on inquiries received from
industry, DEA is conducting a
comprehensive review of the exempt
chemical preparation regulations. DEA’s
regulations at 21 CFR 1308.24(a) state
that approved chemical preparations are
exempt from certain provisions of both
Subchapter I and Subchapter II of the
CSA: ‘‘The chemical preparations and
mixtures approved pursuant to 1308.23
are exempt from application of sections
302, 303, 305, 306, 307, 308, 309, 1002,
1003 and 1004 of the Act (21 U.S.C.
822–823, 825–829, 952–954) and
1301.74 of this chapter, to the extent
described in paragraphs (b) to (h) of this
section.’’ Pursuant to its regulations,
DEA has provided exemptions from the
application of section 302, 303, 305,
306, 307, 308, 309, 1002, 1003, and 1004
of the Act (21 U.S.C. 822–823, 825–829,
952–954) and 21 CFR 1301.74 since the
implementation of the regulations in the
early 1970s. Until DEA’s analysis of the
exemption regulations is complete, DEA
will continue to review and provide
exemptions to chemical preparations
consistent with the implementing
regulations, when warranted. DEA will
publish a future notice regarding the
outcome of DEA’s review of its
regulations with respect to the
exemption of chemical preparations.
DEPARTMENT OF JUSTICE
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
Opportunity for Comment
Pursuant to 21 CFR 1308.23, any
interested person may submit written
comments on or objections to any
chemical preparation in this order that
has been approved or denied as exempt.
If any comments or objections raise
significant issues regarding any finding
of fact or conclusion of law upon which
this order is based, the Deputy Assistant
Administrator will immediately
suspend the effectiveness of any
applicable part of this order until he
may reconsider the application in light
of the comments and objections filed.
Approved Exempt Chemical
Preparations Are Posted on DEA’s Web
Site
A list of all current exemptions,
including those listed in this order, is
available on DEA’s Web site at https://
www.DEAdiversion.usdoj.gov/
schedules/exempt/exempt_chemlist.pdf.
The dates of applications of all current
exemptions are posted for easy
reference.
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
[FR Doc. 2013–16010 Filed 7–2–13; 8:45 am]
Drug Enforcement Administration
[Docket No. DEA–378]
Proposed Aggregate Production
Quotas for Schedule I and II Controlled
Substances and Proposed
Assessment of Annual Needs for the
List I Chemicals Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine for 2014
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Notice with request for
comments.
AGENCY:
This notice proposes initial
year 2014 aggregate production quotas
for controlled substances in Schedules I
and II of the Controlled Substances Act
(CSA) and assessment of annual needs
for the List I chemicals ephedrine,
pseudoephedrine, and
phenylpropanolamine.
DATES: Electronic comments must be
submitted and written comments must
be postmarked on or before August 2,
2013. The electronic Federal Docket
Management System will not accept
comments after midnight Eastern Time
on the last day of the comment period.
ADDRESSES: To ensure proper handling
of comments, please reference ‘‘Docket
No. DEA–378’’ on all electronic and
written correspondence. DEA
encourages that all comments be
submitted electronically through https://
www.regulations.gov using the
electronic comment form provided on
that site. An electronic copy of this
document is also available at https://
www.regulations.gov for easy reference.
Paper comments that duplicate the
electronic submission are not necessary
as all comments submitted to
www.regulations.gov will be posted for
public review and are part of the official
docket record. Written comments
submitted via regular or express mail
should be sent to the Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODL, 8701
Morrissette Drive, Springfield, VA
22152.
FOR FURTHER INFORMATION CONTACT: John
W. Partridge, Executive Assistant, Office
of Diversion Control, Drug Enforcement
Administration, 8701 Morrissette Drive,
SUMMARY:
E:\FR\FM\03JYN1.SGM
03JYN1
]]>Agencies
[Federal Register Volume 78, Number 128 (Wednesday, July 3, 2013)]
[Notices]
[Pages 40175-40186]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16010]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-372]
Exempt Chemical Preparations Under the Controlled Substances Act
AGENCY: Drug Enforcement Administration (DEA), Department of Justice.
ACTION: Order with opportunity for comment.
-----------------------------------------------------------------------
SUMMARY: The applications for exempt chemical preparations received by
DEA between July 1, 2012, and March 31, 2013, as listed below, were
accepted for filing and have been approved or denied as indicated.
DATES: Electronic comments must be submitted and written comments must
be postmarked on or before September 3, 2013. The electronic Federal
Docket Management System will not accept comments after midnight
Eastern Time on the last day of the comment period.
ADDRESSES: To ensure proper handling of comments, please reference
``Docket No. DEA-372'' on all electronic and written correspondence.
DEA encourages that all comments be submitted electronically through
https://www.regulations.gov using the electronic comment form provided
on that site. An electronic copy of this document is also available at
https://www.regulations.gov for easy reference. Paper comments that
duplicate the electronic submission are not necessary as all comments
submitted to www.regulations.gov will be posted for public review and
are part of the official docket record. Written comments submitted via
regular or express mail should be sent to the Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODL,
8701 Morrissette Drive, Springfield, Virginia 22152.
[[Page 40176]]
FOR FURTHER INFORMATION CONTACT: John W. Partridge, Executive
Assistant, Office of Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701 Morrissette Drive, Springfield,
Virginia 22152; Telephone: (202) 307-7165.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received are considered part of the
public record and made available for public inspection online at https://www.regulations.gov and in the DEA's public docket. Such information
includes personal identifying information (such as your name, address,
etc.) voluntarily submitted by the commenter.
If you want to submit personal identifying information (such as
your name, address, etc.) as part of your comment, but do not want it
to be posted online or made available in the public docket, you must
include the phrase ``PERSONAL IDENTIFYING INFORMATION'' in the first
paragraph of your comment. You must also place all the personal
identifying information you do not want posted online or made available
in the public docket in the first paragraph of your comment and
identify what information you want redacted.
If you want to submit confidential business information as part of
your comment, but do not want it to be posted online or made available
in the public docket, you must include the phrase ``CONFIDENTIAL
BUSINESS INFORMATION'' in the first paragraph of your comment. You must
also prominently identify confidential business information to be
redacted within the comment. If a comment has so much confidential
business information that it cannot be effectively redacted, all or
part of that comment may not be posted online or made available in the
public docket.
Personal identifying information and confidential business
information identified and located as set forth above will be redacted,
and the comment, in redacted form, will be posted online and placed in
DEA's public docket file. Please note that the Freedom of Information
Act applies to all comments received. If you wish to inspect the
agency's public docket file in person by appointment, please see the
FOR FURTHER INFORMATION CONTACT paragraph.
Legal Authority
DEA implements and enforces Titles II and III of the Comprehensive
Drug Abuse Prevention and Control Act of 1970, often referred to as the
Controlled Substances Act and the Controlled Substances Import and
Export Act (codified at Title 21, Chapter 13 of the U.S.C.), as amended
(CSA). DEA drafts and publishes the implementing regulations for these
statutes in Title 21 of the Code of Federal Regulations (CFR), parts
1300 to 1321. The CSA and its implementing regulations are designed to
prevent, detect, and eliminate the diversion of controlled substances
and listed chemicals into the illicit market while providing for a
sufficient supply of controlled substances and listed chemicals for
legitimate medical, scientific, research, and industrial purposes.
Controlled substances have the potential for abuse and dependence and
are controlled to protect the public health and safety.
Section 201 of the CSA (21 U.S.C. 811) authorizes the Attorney
General, by regulation, to exempt from certain provisions of the CSA
certain compounds, mixtures, or preparations containing a controlled
substance, if he finds that such compounds, mixtures, or preparations
meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).\1\ DEA
regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria
by which the DEA Deputy Assistant Administrator may exempt a chemical
preparation or mixture from the application of certain provisions of
the CSA. The Deputy Assistant Administrator may, pursuant to 21 CFR
1308.23(f), modify or revoke the criteria by which exemptions are
granted and modify the scope of exemptions at any time.
---------------------------------------------------------------------------
\1\ This authority has been delegated from the Attorney General
to the Administrator of the DEA by 28 CFR 0.100 and subsequently
redelegated to the Deputy Assistant Administrator pursuant to the
Appendix to Subpart R of 28 CFR 0.104.
---------------------------------------------------------------------------
Exempt Chemical Preparation Applications Submitted Between July 1,
2012, and March 31, 2013
The Deputy Assistant Administrator received applications between
July 1, 2012, and March 31, 2013, requesting exempt chemical
preparation status pursuant to 21 CFR 1308.23. Pursuant to the criteria
stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Deputy
Assistant Administrator has found that each of the compounds, mixtures,
and preparations described in Chart I below is intended for laboratory,
industrial, educational, or special research purposes and not for
general administration to a human being or other animal and either: (1)
Contains no narcotic controlled substance and is packaged in such a
form or concentration that the packaged quantity does not present any
significant potential for abuse; or (2) contains either a narcotic or
non-narcotic controlled substance and one or more adulterating or
denaturing agents in such a manner, combination, quantity, proportion,
or concentration that the preparation or mixture does not present any
potential for abuse; if the preparation or mixture contains a narcotic
controlled substance, it must be formulated in such a manner that it
incorporates methods of denaturing or other means so that the
preparation or mixture is not liable to be abused or have ill effects
if abused, and so that the narcotic substance cannot in practice be
removed.
Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23,
and 21 CFR 1308.24, the Deputy Assistant Administrator has determined
that each of the chemical preparations or mixtures generally described
in Chart I below and specifically described in the application
materials received by DEA, are exempt, to the extent described in 21
CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308,
309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of
the CSA, and 21 CFR 1301.74, as of the date listed below that was
provided in the approval letters to the individual requesters.
Chart I
----------------------------------------------------------------------------------------------------------------
Application
Supplier Product name Form date
----------------------------------------------------------------------------------------------------------------
AccuStandard, Inc..................... APP-9-086, a,a- Amber ampule: 1 mL...... 1/28/2013
Dimethylphenethylamine.
AccuStandard, Inc..................... APP-9-086-20X, a,a- Amber ampule: 1 mL...... 1/28/2013
Dimethylphenethylamine.
AccuStandard, Inc..................... AS-E1179, Chloral hydrate..... Amber ampule: 1 mL...... 1/28/2013
AccuStandard, Inc..................... CLP-HC-X1, Composite Mix Amber ampule: 1 mL...... 1/28/2013
3A.
AccuStandard, Inc..................... M-551.1B, Disinfectant by- Amber ampule: 1 mL...... 1/28/2013
products.
[[Page 40177]]
AccuStandard, Inc..................... M-551B, Disinfectant by- Amber ampule: 1 mL...... 1/28/2013
products.
AccuStandard, Inc..................... M-551B-2, Chloral hydrate..... Amber ampule: 1 mL...... 1/28/2013
AccuStandard, Inc..................... M-8015B/5031-21, Paraldehyde.. Amber ampule: 1 mL...... 1/28/2013
AccuStandard, Inc..................... M-8206B-05, Additional VOC's Amber ampule: 1 mL...... 1/28/2013
by Method 8206B.
AccuStandard, Inc..................... M-8270-02, Semi-Volatile by Amber ampule: 1 mL...... 1/28/2013
Capillary Column GC/MS Mix 2.
AccuStandard, Inc..................... M-8270-04-ASL, Method 8270B-- Amber ampule: 1 mL...... 1/28/2013
Base/Neutrals Mix.
AccuStandard, Inc..................... M-8270-23-R1, Method 8270 Semi- Amber ampule: 1 mL...... 1/28/2013
Volatile Additions.
AccuStandard, Inc..................... M-E-1179-M, Chloral hydrate... Amber ampule: 1 mL...... 1/28/2013
Agilent Technologies.................. Veterinary Drugs Checkout Mix. Amber ampule: 1 mL...... 8/3/2012
Agilent Technologies.................. Veterinary Drugs Comprehensive Amber ampule: 1 mL...... 8/3/2012
Mix--Submix 6.
Agilent Technologies.................. Forensic Toxicology Amber ampule: 1 mL...... 8/3/2012
Comprehensive Mix--Submix 3.
Agilent Technologies.................. Forensic Toxicology Amber ampule: 1 mL...... 8/3/2012
Comprehensive Mix--Submix 5.
Agilent Technologies.................. Forensic Toxicology Amber ampule: 1 mL...... 8/3/2012
Comprehensive Mix--Submix 2.
Agilent Technologies.................. Forensic Toxicology Checkout Amber ampule: 1 mL...... 8/3/2012
Mix.
Agilent Technologies.................. Forensic Toxicology Amber ampule: 1 mL...... 12/6/2012
Comprehensive Mix--Submix 1.
Alltech Associates, Inc............... 2C-T-2 Quik Check, 1.0 mg/mL.. Glass ampule: 1 mL...... 9/26/2012
Alltech Associates, Inc............... 5-MeO-DMT Quick Check, 1.0 mg/ Glass ampule: 1 mL...... 9/26/2012
mL.
Alltech Associates, Inc............... Carisoprodol Quik Check, 1.0 Glass ampule: 1 mL...... 9/26/2012
mg/mL.
American Proficiency Institute........ American Proficiency Institute Amber bottle: 7 mL...... 12/5/2012
SHBG/Testosterone.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 8/14/2012
Control Oral Fluid, OF23.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 8/14/2012
Control Urine, SD17.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 9/27/2012
Control Urine, MC176.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 10/23/2012
Control Urine, MC179.
Biochemical Diagnostics, Inc.......... Salivabuse Custom Liquid Glass vials: 1 ml-200 mL 10/23/2012
Control Oral Fluid, OF25.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 11/5/2012
Control Urine, MC177.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 1/24/2013
Control Urine, MC178.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 1/24/2013
Control Oral Fluid, OF24.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 1/29/2013
Control Urine, MC181.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 3/12/2013
Control Urine, MC183.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 3/12/2013
Control Urine, MC184.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 3/14/2013
Control Urine, MC180.
Bio-Rad Laboratories.................. Liquichek Immunoassay Plus Box: 3 vials, 2.5 mL 11/14/2012
Control Trilevel MiniPak. each.
Bio-Rad Laboratories.................. Liquichek Immunoassay Plus Box: 12 vials, 5 mL each 11/21/2012
Control Level 1,2 and 3,
Trilevel.
Bio-Rad Laboratories.................. Liquid Assayed Multiqual Box: 6 vials, 5 mL each. 11/21/2012
Premium, Levels 1-3.
Bio-Rad Laboratories.................. Liquid Assayed Multiqual Box: 3 vials, 5 mL each. 11/21/2012
Premium, Trilevel Minipak.
Bio-Rad Laboratories.................. Lyphocheck Urine Toxicology Glass vial: 25 mL....... 1/11/2013
Control MiniPak, Cat. No.
470X.
Bio-Rad Laboratories.................. Liquichek Immunoassay Plus Glass vial: 2.5 mL, Box 2/20/2013
Control Level 1. 12 vials.
Bio-Rad Laboratories.................. Liquichek Immunoassay Plus Glass vial: 2.5 mL, Box 2/20/2013
Control Level 2. 12 vials.
Bio-Rad Laboratories.................. Liquichek Immunoassay Plus Glass vial: 2.5 mL, Box 2/20/2013
Control Level 3. 12 vials.
Cerilliant Corporation................ Benzodiazepine Mix (1 mg/mL).. Glass Ampule: 1 mL...... 7/2/2012
Cerilliant Corporation................ Class C Mix Urinalysis Glass Ampule: 1 mL...... 7/9/2012
Internal Standard Fortified
Morphine.
Cerilliant Corporation................ Spice Cannabinoid Mix 2 (0.1 Amber ampule: 1 mL...... 9/26/2012
mg/mL).
Cerilliant Corporation................ Spice Cannabinoid Mix 3 (0.1 Amber ampule: 1 mL...... 9/26/2012
mg/mL).
Cerilliant Corporation................ Retigabine (1 mg/mL).......... Glass Ampule: 1 mL...... 11/7/2012
Cerilliant Corporation................ - Glass Ampule: 1 mL...... 1/7/2013
Norpseudoephedrine-D3 HCl
(0.1 mg/mL).
Cerilliant Corporation................ Amobarbital-D5 (0.1 mg/mL).... Glass Ampule: 1 mL...... 1/7/2013
Cerilliant Corporation................ 2,5-Dimethoxy-4-(n)- Glass Ampule: 1 mL...... 1/7/2013
propylthiophenethylamine HCl
(2C-T-7 HCl) (1 mg/mL).
Cerilliant Corporation................ Class B Mix Urinalysis Glass ampule: 1 ml...... 1/22/2013
Internal Standard-8 (0.002-
0.2 mg/mL), Pregabalin-D6
(1.0 mg/mL), Codeine-6-beta-
glucoronide (1.0 mg/mL),
Desomorphine (1.0 mg/mL),
Levorphanol-D3 (0.1 mg/mL).
Cerilliant Corporation................ Zaleplon-D4 (0.1 mg/mL)....... Glass Ampule: 1 mL...... 1/31/2013
Cerilliant Corporation................ Retigabine-D4 (0.1 mg/mL)..... Glass ampule: 1ml....... 3/22/2013
Cerilliant Corporation................ Tilidine-D6 HCl (0.1 mg/mL)... Glass ampule: 1ml....... 3/22/2013
Cliniqa Corporation................... TDM Control, Levels 1-3....... Dropper bottle: 5 mL.... 12/4/2012
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, THC Glass vial: 5 ml-4 L.... 10/22/2012
(0.5-50 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, Glass vial: 5 ml-4 L.... 10/22/2012
Methamphetamine (2-200 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, Glass vial: 5 ml-4 L.... 10/22/2012
Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2-
200 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, Glass vial: 5 ml-4 L.... 10/22/2012
Multidrug (THC,
Benzoylecgonine, Amphetamine,
Methamphetamine, Morphine,
Codeine, 6-Acetylmorphine, &
PCP) at 0.5-50 ng/mL.
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 10/22/2012
THC (0.5-50 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 10/22/2012
Methamphetamine (2-200 ng/mL).
[[Page 40178]]
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 10/22/2012
Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2-
200 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 10/22/2012
Multidrug (THC,
Benzoylecgonine, Amphetamine,
Methamphetamine, Morphine,
Codeine, 6-Acetylmorphine, &
PCP) at 0.5-200 ng/mL.
Environmental Resource Associates USGS-BQS LS 4434 Mix 1........ Glass Ampule: 2 mL...... 8/9/2012
(ERA).
Environmental Resource Associates USGS-BQS LS 4434 Mix 2........ Glass Ampule: 2 mL...... 8/9/2012
(ERA).
Immunalysis Corporation............... Tapentadol Calibrator Level 1 Glass vial: 10 mL....... 12/11/2012
(100 ng/mL).
Immunalysis Corporation............... Tapentadol Calibrator Level 2 Glass vial: 10 mL....... 12/11/2012
(200 ng/mL).
Immunalysis Corporation............... Tapentadol Calibrator Level 3 Glass vial: 10 mL....... 12/11/2012
(500 ng/mL).
Immunalysis Corporation............... Tapentadol Calibrator Level 4 Glass vial: 10 mL....... 12/11/2012
(1,000 ng/mL).
Immunalysis Corporation............... Tapentadol Low Control (150 ng/ Glass vial: 10 mL....... 12/11/2012
mL).
Immunalysis Corporation............... Tapentadol High Control (250 Glass vial: 10 mL....... 12/11/2012
ng/mL).
LGC Limited........................... (S)-(+)-Amphetamine Glass vial: 1 mL........ 9/24/2012
(Dextroamphetamine) 1.0 mg/mL
in Methanol.
LGC Limited........................... rac-Amphetamine 0.1 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... rac-Amphetamine 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... rac-Amphetamine-D11 0.1 mg/mL Glass vial: 1 mL........ 9/24/2012
in Methanol.
LGC Limited........................... rac-Amphetamine-D11 1.0 mg/mL Glass vial: 1 mL........ 9/24/2012
in Methanol.
LGC Limited........................... rac-Amphetamine-D5 (D-label on Glass vial: 1 mL........ 9/24/2012
ring) 0.1 mg/mL in Methanol.
LGC Limited........................... Methamphetamine ((S)-(+)- Glass vial: 1 mL........ 9/24/2012
Methamphetamine) 1.0 mg/mL in
Methanol.
LGC Limited........................... rac-Methamphetamine 0.1 mg/mL Glass vial: 1 mL........ 9/24/2012
in Methanol.
LGC Limited........................... rac-Methamphetamine 1.0 mg/mL Glass vial: 1 mL........ 9/24/2012
in Methanol.
LGC Limited........................... rac-Methamphetamine-D5 0.1 mg/ Glass vial: 1 mL........ 9/24/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D5 1.0 mg/ Glass vial: 1 mL........ 9/24/2012
mL in Methanol.
LGC Limited........................... Methcathinone Hydrochloride Glass vial: 1 mL........ 9/24/2012
1.0 mg/mL in Methanol (as
free base).
LGC Limited........................... Methylphenidate Hydrochloride Glass vial: 1 mL........ 9/24/2012
1.0 mg/mL in Methanol (as
free base).
LGC Limited........................... Amobarbital 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Pentobarbital 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Pentobarbital-D5 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Pentobarbital-D5 0.1 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Secobarbital 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... rac-MDA-D5 (rac-3,4- Glass vial: 1 mL........ 9/24/2012
Methylenedioxyamphetamine-D5)
0.1 mg/mL Methanol.
LGC Limited........................... rac-MDA-D5 (rac-3,4- Glass vial: 1 mL........ 9/24/2012
Methylenedioxyamphetamine-D5)
1.0 mg/mL Methanol.
LGC Limited........................... rac-MBDB HCl (rac-N-Methyl-1- Glass vial: 1 mL........ 9/24/2012
(3,4-Methylenedioxyphenyl)-2-
butanamine Hydrochloride) 1.0
mg/mL Methanol (as free base).
LGC Limited........................... rac-MBDB-D5 (rac-N-Methyl-1- Glass vial: 1 mL........ 9/24/2012
(3,4-Methylenedioxyphenyl)-2-
butanamine-D5) 0.1 mg/mL
Methanol.
LGC Limited........................... rac-MDEA-D5 (rac-3,4- Glass vial: 1 mL........ 9/24/2012
Methylenedioxy-N-
ethylamphetamine-D5) 0.1 mg/
mL Methanol.
LGC Limited........................... rac-MDEA-D5 (rac-3,4- Glass vial: 1 mL........ 9/24/2012
Methylenedioxy-N-
ethylamphetamine-D5) 1.0 mg/
mL Methanol.
LGC Limited........................... rac-MDEA-D6 (rac-3,4- Glass vial: 1 mL........ 9/24/2012
Methylenedioxy-N-
ethylamphetamine-D6) 0.1 mg/
mL Methanol.
LGC Limited........................... rac-MDMA-D5 (rac-3,4- Glass vial: 1 mL........ 9/24/2012
Methylenedioxymethamphetamine-
D5) 0.1 mg/mL Methanol.
LGC Limited........................... rac-MDMA-D5 (rac-3,4- Glass vial: 1 mL........ 9/24/2012
Methylenedioxymethamphetamine-
D5) 1.0 mg/mL Methanol.
LGC Limited........................... Phencyclidine (PCP) 1.0 mg/mL Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Phencyclidine-D5 (PCP-D5) 0.1 Glass vial: 1 mL........ 9/24/2012
mg/mL in Methanol.
LGC Limited........................... Phencyclidine-D5 (PCP-D5) 1.0 Glass vial: 1 mL........ 9/24/2012
mg/mL Methanol.
LGC Limited........................... Codeine 0.1 mg/mL in Methanol. Glass vial: 1 mL........ 9/24/2012
LGC Limited........................... Codeine 1.0 mg/mL in Methanol. Glass vial: 1 mL........ 9/24/2012
LGC Limited........................... Codeine-D3 0.1 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Codeine-D3 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Codeine-D6 0.1 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Codeine-D6 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Isocodeine 0.1 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Norcodeine 0.01 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Norcodeine 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Codeine N-Oxide 0.01 mg/mL Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Oxycodone-D3 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
[[Page 40179]]
LGC Limited........................... Oxycodone-D6 0.1 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Oxycodone-D6 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Hydromorphone 1.0 mg/mL Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Norhydromorphone Hydrochloride Glass vial: 1 mL........ 9/24/2012
1.0 mg/mL Methanol (as free
base).
LGC Limited........................... Pethidine (Meperidine) 1.0 mg/ Glass vial: 1 mL........ 9/24/2012
mL in Methanol.
LGC Limited........................... Pethidine-D4 (Meperidine-D4) Glass vial: 1 mL........ 9/24/2012
0.1 mg/mL in Methanol.
LGC Limited........................... Pethidine-D4 (Meperidine-D4) Glass vial: 1 mL........ 9/24/2012
1.0 mg/mL in Methanol.
LGC Limited........................... Morphine 0.1 mg/mL in Methanol Glass vial: 1 mL........ 9/24/2012
LGC Limited........................... Morphine 1.0 mg/mL in Methanol Glass vial: 1 mL........ 9/24/2012
LGC Limited........................... Morphine 3-beta-D-Glucuronide Glass vial: 1 mL........ 9/24/2012
0.1 mg/mL in Methanol/Water
(\1/1\).
LGC Limited........................... Morphine 3-beta-D-Glucuronide Glass vial: 1 mL........ 9/24/2012
1.0 mg/mL in Methanol with
0.05 percent Sodium Hydroxide
(w/v).
LGC Limited........................... Morphine 6-beta-D-Glucuronide Glass vial: 1 mL........ 9/24/2012
0.1 mg/mL in Methanol/Water
(\1/1\).
LGC Limited........................... Morphine 6-beta-D-Glucuronide Glass vial: 1 mL........ 9/24/2012
1.0 mg/mL Water/Methanol (80/
20).
LGC Limited........................... Morphine-D3 0.1 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Morphine-D3 1.0 mg/mL in Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Morphine N-Oxide 0.01 mg/mL Glass vial: 1 mL........ 9/24/2012
Methanol.
LGC Limited........................... Normorphine 1.0 mg/mL Methanol Glass vial: 1 mL........ 9/24/2012
LGC Limited........................... rac-Amphetamine-D10 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... rac-Amphetamine-D5 (D-label on Glass vial: 1 mL........ 11/30/2012
ring) 0.1 mg/mL in Methanol.
LGC Limited........................... rac-Amphetamine-D5 (D-label on Glass vial: 1 mL........ 11/30/2012
side chain) 0.1 mg/mL in
Methanol.
LGC Limited........................... rac-Amphetamine-D5 (D-label on Glass vial: 1 mL........ 11/30/2012
side chain) 1.0 mg/mL in
Methanol.
LGC Limited........................... rac-Amphetamine-D6 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... rac-Amphetamine-D6 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... rac-Amphetamine-D8 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... rac-Amphetamine-D8 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... rac-Methamphetamine-D11 0.1 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D11 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D14 0.1 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D14 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D8 0.1 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D8 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D9 0.1 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... rac-Methamphetamine-D9 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol.
LGC Limited........................... (+)-Norpseudoephedrine Glass vial: 1 mL........ 11/30/2012
Hydrochloride (Cathine
Hydrochloride) 0.1 mg/mL in
Methanol (as free base).
LGC Limited........................... (R)-(+)-Cathinone Glass vial: 1 mL........ 11/30/2012
Hydrochloride 1.0 mg/mL in
Methanol (as free base).
LGC Limited........................... (S)-(-)-Cathinone Glass vial: 1 mL........ 11/30/2012
Hydrochloride 1.0 mg/mL in
Methanol (as free base).
LGC Limited........................... (S)-(-)-Methcathinone Glass vial: 1 mL........ 11/30/2012
Hydrochloride 1.0 mg/mL in
Methanol (as free base).
LGC Limited........................... Phentermine 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Fenfluramine Hydrochloride 1.0 Glass vial: 1 mL........ 11/30/2012
mg/mL in Methanol (as free
base).
LGC Limited........................... Methylphenidate-D9 Glass vial: 1 mL........ 11/30/2012
Hydrochloride 0.1 mg/mL in
Methanol.
LGC Limited........................... Pipradrol Hydrochloride 0.1 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol (as free base).
LGC Limited........................... Pipradrol Hydrochloride 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol (as free base).
LGC Limited........................... GHB Sodium Salt (Sodium Glass vial: 1 mL........ 11/30/2012
Gammahydroxybutyrate) 1.0 mg/
mL in Methanol (as free acid).
LGC Limited........................... GHB-D6 Sodium Salt (Sodium Glass vial: 1 mL........ 11/30/2012
Gammahydroxybutyrate-D6) 0.1
mg/mL in Methanol (as free
acid).
LGC Limited........................... GHB-D6 Sodium Salt (Sodium Glass vial: 1 mL........ 11/30/2012
Gammahydroxybutyrate-D6) 1.0
mg/mL in Methanol (as free
acid).
LGC Limited........................... Hexobarbital 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Methohexital 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Methohexital-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Phenobarbital 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Phenobarbital-D5 (D-label on Glass vial: 1 mL........ 11/30/2012
ring) 0.1 mg/mL in Methanol.
LGC Limited........................... Phenobarbital-D5 (D-label on Glass vial: 1 mL........ 11/30/2012
ring) 1.0 mg/mL in Methanol.
LGC Limited........................... Phenobarbital-D5 (D-label on Glass vial: 1 mL........ 11/30/2012
side chain) 0.1 mg/mL in
Methanol.
[[Page 40180]]
LGC Limited........................... Phenobarbital-D5 (D-label on Glass vial: 1 mL........ 11/30/2012
side chain) 1.0 mg/mL in
Methanol.
LGC Limited........................... Methaqualone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Methaqualone-D7 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Clonazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Clonazepam-D4 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Chlordiazepoxide 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Chlordiazepoxide-D5 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... Bromazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Bromazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Clobazam 1.0 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Delorazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Estazolam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Estazolam-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Flunitrazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Flunitrazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Flunitrazepam-D7 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Prazepam 1.0 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Prazepam-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Diazepam 0.1 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Diazepam 1.0 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Diazepam-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Diazepam-D5 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Flurazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Flurazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Lormetazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Zaleplon 1.0 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Pregabalin 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Pregabalin-D6 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Zolpidem Tartrate 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol (as free base).
LGC Limited........................... Zolpidem-D6 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Zopiclone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Zopiclone Oxide 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Zopiclone-D4 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Meprobamate 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Nitrazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Nitrazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Nitrazepam-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Oxazepam 1.0 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Oxazepam-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Oxazepam-D5 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Nordazepam (Nordiazepam) 0.1 Glass vial: 1 mL........ 11/30/2012
mg/mL in Methanol.
LGC Limited........................... Nordazepam (Nordiazepam) 1.0 Glass vial: 1 mL........ 11/30/2012
mg/mL in Methanol.
LGC Limited........................... Nordazepam-D5 (Nordiazepam-D5) Glass vial: 1 mL........ 11/30/2012
0.1 mg/mL in Methanol.
LGC Limited........................... Nordazepam-D5 (Nordiazepam-D5) Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Methanol.
LGC Limited........................... Alprazolam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Alprazolam-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Alprazolam-D5 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Methyltestosterone (17alpha- Glass vial: 1 mL........ 11/30/2012
Methyltestosterone) 1.0 mg/mL
in Acetonitrile.
LGC Limited........................... Midazolam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Midazolam-D4 Maleate 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol (as free base).
LGC Limited........................... Lorazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Lorazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Lorazepam Acetate ((3RS)-7- Glass vial: 1 mL........ 11/30/2012
Chloro-5-(2-chlorophenyl)-2-
oxo-2,3-dihydro-1H-1,4-
benzodiazepin-3-yl Acetate)
0.1 mg/mL in Acetonitrile.
LGC Limited........................... Lorazepam-D4 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Lorazepam-D4 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Tetrazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Triazolam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Triazolam-D4 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Temazepam 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Temazepam 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Temazepam-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Temazepam-D5 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Androstanolone (5alpha- Glass vial: 1 mL........ 11/30/2012
Dihydrotestosterone,
Stanolone) 1.0 mg/mL in
Acetonitrile.
LGC Limited........................... Androstenedione (Androst-4-ene- Glass vial: 1 mL........ 11/30/2012
3, 17-dione) 1.0 mg/mL in
Acetonitrile.
[[Page 40181]]
LGC Limited........................... Boldenone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Fluoxymesterone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Mesterolone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Methandienone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Nandrolone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Norandrostenedione (19- Glass vial: 1 mL........ 11/30/2012
Norandrost-4-ene-3,17-dione)
1.0 mg/mL in Acetonitrile.
LGC Limited........................... Norethandrolone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Stanozolol 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Stanozolol-D3 0.1 mg/mL in 1,2- Glass vial: 1 mL........ 11/30/2012
Dimethoxyethane.
LGC Limited........................... Testosterone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Testosterone Benzoate 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Acetonitrile.
LGC Limited........................... Testosterone Isocaproate 1.0 Glass vial: 1 mL........ 11/30/2012
mg/mL in Acetonitrile.
LGC Limited........................... Testosterone Propionate 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Acetonitrile.
LGC Limited........................... Trenbolone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... RCS-4 (DD-001, (4- Glass vial: 1 mL........ 11/30/2012
Methoxyphenyl)(1-pentylindol-
3-yl)methanone) 1.0 mg/mL in
Acetonitrile.
LGC Limited........................... JWH-081 ((4-Methoxynaphthalen- Glass vial: 1 mL........ 11/30/2012
1-yl)(1-pentylindol-3-
yl)methanone) 1.0 mg/mL in
Acetonitrile.
LGC Limited........................... JWH-122 ((4-Methylnaphthalen-1- Glass vial: 1 mL........ 11/30/2012
yl)(1-pentylindol-3-
yl)methanone) 1.0 mg/mL in
Acetonitrile.
LGC Limited........................... JWH-203 (2-(2-Chlorophenyl)-1- Glass vial: 1 mL........ 11/30/2012
(1-pentylindol-3-yl)ethanone)
1.0 mg/mL in Acetonitrile.
LGC Limited........................... Ketamine Hydrochloride 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol (as free base).
LGC Limited........................... Ketamine-D4 Hydrochloride 0.1 Glass vial: 1 mL........ 11/30/2012
mg/mL in Methanol (as free
base).
LGC Limited........................... Iso-LSD (Lysergic Acid Glass vial: 1 mL........ 11/30/2012
Diethylamide) 0.1 mg/mL in
Acetonitrile.
LGC Limited........................... LAMPA (Lysergic Acid N-Methyl- Glass vial: 1 mL........ 11/30/2012
N-propylamide) 0.025 mg/mL in
Acetonitrile.
LGC Limited........................... LSD (Lysergic Acid Glass vial: 1 mL........ 11/30/2012
Diethylamide) 0.025 mg/mL in
Acetonitrile.
LGC Limited........................... LSD-D3 (Lysergic Acid Glass vial: 1 mL........ 11/30/2012
Diethylamide-D3) 0.025 mg/mL
in Acetonitrile.
LGC Limited........................... PMA HCl (p-Methoxyamphetamine) Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Methanol (as
free base).
LGC Limited........................... rac-MDA (rac-3,4- Glass vial: 1 mL........ 11/30/2012
Methylenedioxyamphetamine)
1.0 mg/mL in Methanol.
LGC Limited........................... rac-MDEA (rac-3,4- Glass vial: 1 mL........ 11/30/2012
Methylenedioxy-N-
ethylamphetamine) 1.0 mg/mL
in Methanol.
LGC Limited........................... 1-Methylamino-1-(3,4- Glass vial: 1 mL........ 11/30/2012
methylenedioxyphenyl)propane
Hydrochloride 1.0 mg/mL in
Methanol (as free base).
LGC Limited........................... rac-BDB HCl (rac-3,4- Glass vial: 1 mL........ 11/30/2012
Methylenedioxyphenyl-2-
butanamine Hydrochloride) 1.0
mg/mL in Methanol (as free
base).
LGC Limited........................... rac-MDMA (rac-3,4- Glass vial: 1 mL........ 11/30/2012
Methylenedioxymethamphetamine
) 1.0 mg/mL in Methanol.
LGC Limited........................... Bufotenine 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Methylone Hydrochloride 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol (as free base).
LGC Limited........................... Methylone-D3 Hydrochloride 0.1 Glass vial: 1 mL........ 11/30/2012
mg/mL in Methanol (as free
base).
LGC Limited........................... AM-694 (1-(5-Fluoropentyl)-3- Glass vial: 1 mL........ 11/30/2012
(2-iodobenzoyl)indole) 1.0 mg/
mL in Acetonitrile.
LGC Limited........................... Cocaine 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Cocaine-D3 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Cocaine-D3 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Norcocaine Hydrochloride 1.0 Glass vial: 1 mL........ 11/30/2012
mg/mL in Acetonitrile (as
free base).
LGC Limited........................... Norcocaine-D3 Hydrochloride Glass vial: 1 mL........ 11/30/2012
0.1 mg/mL in Acetonitrile (as
free base).
LGC Limited........................... O-Methylcodeine 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Buprenorphine 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Buprenorphine 3-beta-D- Glass vial: 1 mL........ 11/30/2012
Glucuronide 0.1 mg/mL in
Methanol.
LGC Limited........................... Buprenorphine-D4 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Dihydrocodeine Hydrochloride Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Methanol (as
free base).
LGC Limited........................... Dihydrocodeine-D6 Glass vial: 1 mL........ 11/30/2012
Hydrochloride 0.1 mg/mL in
Methanol (as free base).
LGC Limited........................... Noroxycodone Hydrochloride 1.0 Glass vial: 1 mL........ 11/30/2012
mg/mL in Methanol (as free
base).
[[Page 40182]]
LGC Limited........................... Noroxycodone-D3 Hydrochloride Glass vial: 1 mL........ 11/30/2012
0.1 mg/mL in Methanol (as
free base).
LGC Limited........................... Oxycodone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Oxycodone-D3 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Dihydromorphine 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Hydromorphone-D3 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Anhydroecgonine Hydrochloride Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Acetonitrile (as
free base).
LGC Limited........................... Anhydroecgonine Methyl Ester Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Acetonitrile.
LGC Limited........................... Benzoylecgonine 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Benzoylecgonine-D3 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... Benzoylecgonine-D3 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... Benzoylecgonine-D8 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... Benzoylecgonine-D8 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol.
LGC Limited........................... Cocaethylene Glass vial: 1 mL........ 11/30/2012
(Benzoylethylecgonine) 1.0 mg/
mL in Acetonitrile.
LGC Limited........................... Cocaethylene-D3 Glass vial: 1 mL........ 11/30/2012
(Benzoylethylecgonine-D3) 0.1
mg/mL in Acetonitrile.
LGC Limited........................... Cocaethylene-D8 Glass vial: 1 mL........ 11/30/2012
(Benzoylethylecgonine-D8) 0.1
mg/mL in Acetonitrile.
LGC Limited........................... Ecgonine 1.0 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Ecgonine Ethyl Ester 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... Ecgonine Hydrochloride 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Methanol (as free base).
LGC Limited........................... Ecgonine Methyl Ester 0.1 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Acetonitrile.
LGC Limited........................... Ecgonine Methyl Ester 1.0 mg/ Glass vial: 1 mL........ 11/30/2012
mL in Acetonitrile.
LGC Limited........................... Ecgonine-D3 Hydrochloride 0.1 Glass vial: 1 mL........ 11/30/2012
mg/mL in Methanol (as free
base).
LGC Limited........................... Ecgonine-D3 Methyl Ester 0.1 Glass vial: 1 mL........ 11/30/2012
mg/mL in Acetonitrile.
LGC Limited........................... Ethylmorphine 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Hydrocodone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Hydrocodone-D3 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Hydrocodone-D6 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Norhydrocodone Hydrochloride Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Methanol (as
free base).
LGC Limited........................... Heroin (Diacetylmorphine) 1.0 Glass vial: 1 mL........ 11/30/2012
mg/mL in Acetonitrile.
LGC Limited........................... Heroin-D9 (Diacetylmorphine- Glass vial: 1 mL........ 11/30/2012
D9) 0.1 mg/mL in Acetonitrile.
LGC Limited........................... Heroin-D9 (Diacetylmorphine- Glass vial: 1 mL........ 11/30/2012
D9) 1.0 mg/mL in Acetonitrile.
LGC Limited........................... rac-Methadone 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... rac-Methadone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... rac-Methadone-D3 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... rac-Methadone-D3 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... rac-Methadone-D9 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... rac-Methadone-D9 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Dextropropoxyphene 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... Dextropropoxyphene 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... rac-Propoxyphene-D11 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... rac-Propoxyphene-D11 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... rac-Propoxyphene-D5 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... rac-Propoxyphene-D5 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... 6-Acetylmorphine 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... 6-Acetylmorphine 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... 6-Acetylmorphine-D3 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... 6-Acetylmorphine-D3 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... 6-Acetylmorphine-D6 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... 6-Acetylmorphine-D6 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Acetonitrile.
LGC Limited........................... Acetylcodeine 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Acetylcodeine 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
LGC Limited........................... Nordihydromorphine Glass vial: 1 mL........ 11/30/2012
Hydrochloride 1.0 mg/mL in
Methanol (as free base).
LGC Limited........................... Oxymorphone 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Oxymorphone-D3 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Oxymorphone-D3 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Noroxymorphone Hydrochloride Glass vial: 1 mL........ 11/30/2012
0.1 mg/mL in Methanol (as
free base).
LGC Limited........................... Noroxymorphone Hydrochloride Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Methanol (as
free base).
LGC Limited........................... Butorphanol Tartrate 1.0 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol (as free base).
LGC Limited........................... Sufentanil Citrate 0.1 mg/mL Glass vial: 1 mL........ 11/30/2012
in Methanol (as free base).
[[Page 40183]]
LGC Limited........................... cis-Tilidine (Ethyl (1R,2RS)-2- Glass vial: 1 mL........ 11/30/2012
(Dimethylamino)-1-
phenylcyclohex-3-
enecarboxylate) 0.1 mg/mL in
Acetonitrile.
LGC Limited........................... Tilidine 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Acetonitrile.
Microgenics Corporation............... Abbott TDM Multiconstituent Box: 7 vials; 5 mL each. 7/2/2012
Calibrator (CAL 1-6) Catalog
Number: 5P04-01.
Microgenics Corporation............... Thermo Scientific DRI Opiate Vial: 18 mL, Box: 3 1/30/2013
Assay Catalog Number: vials.
100014602.
Microgenics Corporation............... Thermo Scientific DRI Vial: 18 mL, Box: 3 1/30/2013
Cannabinoid Assay Catalog vials.
Number: 10014665.
Microgenics Corporation............... Thermo Scientific Vial: 18 mL, Box: 3 1/30/2013
Phencyclidine Assay Catalog vials.
Number: 10014673.
Microgenics Corporation............... Thermo Scientific Ecstacy Vial: 18 mL, Box: 3 1/30/2013
Assay Catalog Number: vials.
10014681.
Microgenics Corporation............... Thermo Scientific CEDIA Vial: 5 mL; Box: 1 vial. 2/11/2013
Methamphetamine OFT
Calibrator 1: Catalog Number
10016362.
Microgenics Corporation............... Thermo Scientific CEDIA Vial: 5 mL; Box: 1 vial. 2/11/2013
Methamphetamine OFT
Calibrator 2: Catalog Number
10063.
Microgenics Corporation............... Thermo Scientific CEDIA Vial: 5 mL; Box: 1 vial. 2/11/2013
Methamphetamine OFT
Calibrator 3: Catalog Number
10016364.
Microgenics Corporation............... Thermo Scientific CEDIA Vial: 10 mL; Box: 1 vial 2/11/2013
Methamphetamine OFT Control
1: Catalog Number 10017686.
Microgenics Corporation............... Thermo Scientific CEDIA Vial: 10 mL; Box: 1 vial 2/11/2013
Methamphetamine OFT Control
2: Catalog Number 10017687.
Microgenics Corporation............... Thermo Scientific CEDIA Vial: 10 mL; Box: 1 vial 2/11/2013
Methamphetamine OFT Control
3: Catalog Number 1007688.
Microgenics Corporation............... Thermo Scientific CEDIA Multi- Vial: 10 mL; Box: 1 vial 2/11/2013
Drug OFT Calibrator 1:
Catalog Number 10016882.
Microgenics Corporation............... Thermo Scientific CEDIA Multi- Vial: 10 mL; Box: 1 vial 2/11/2013
Drug OFT Calibrator 2:
Catalog Number 10016883.
Microgenics Corporation............... Thermo Scientific CEDIA Multi- Vial: 10 mL; Box: 1 vial 2/11/2013
Drug OFT Calibrator 3:
Catalog Number 10016884.
Microgenics Corporation............... Thermo Scientific CEDIA Multi- Vial: 15 mL; Box: 1 vial 2/11/2013
Drug OFT Control 1: Catalog
Number 10017711.
Microgenics Corporation............... Thermo Scientific CEDIA Multi- Vial: 15 mL; Box: 1 vial 2/11/2013
Drug OFT Control 2: Catalog
Number 10017712.
Microgenics Corporation............... Thermo Scientific CEDIA Multi- Vial: 15 mL; Box: 1 vial 2/11/2013
Drug OFT Control 3: Catalog
Number 10017713.
Microgenics Corporation............... Thermo Scientific CEDIA THC Vial: 5 mL; Box: 1 vial. 2/11/2013
OFT Calibrator 1: Catalog
Number 10016700.
Microgenics Corporation............... Thermo Scientific CEDIA THC Vial: 5 mL; Box: 1 vial. 2/11/2013
OFT Calibrator 2: Catalog
Number 10016701.
Microgenics Corporation............... Thermo Scientific CEDIA THC Vial: 5 mL; Box: 1 vial. 2/11/2013
OFT Calibrator 3: Catalog
Number 10016702.
Microgenics Corporation............... Thermo Scientific CEDIA THC Vial: 10 mL; Box: 1 vial 2/11/2013
OFT Control 1: Catalog Number
10017702.
Microgenics Corporation............... Thermo Scientific CEDIA THC Vial: 10 mL; Box: 1 vial 2/11/2013
OFT Control 2: Catalog Number
10017703.
Microgenics Corporation............... Thermo Scientific CEDIA THC Vial: 10 mL; Box: 1 vial 2/11/2013
OFT Control 3: Catalog Number
10017704.
Ortho Clinical Diagnostics, Inc....... VITROS Immunodiagnostics Plastic chamber: 8.4 mL. 9/28/2012
Products Testosterone Reagent
Pack.
Ortho Clinical Diagnostics, Inc....... VITROS Immunodiagnostics Plastic chamber: 13.3 mL 9/28/2012
Products Estradiol Reagent
Pack.
Ortho Clinical Diagnostics, Inc....... VITROS Immunodiagnostics Box: 3 vials; 2 mL each. 10/19/2012
Products Testosterone
Calibrators (1-3).
Ortho Clinical Diagnostics, Inc....... VITROS Immunodiagnostics Box: 9 vials; 1 mL each. 10/19/2012
Products Testosterone
Controls (1-3).
Ortho Clinical Diagnostics, Inc....... VITROS Immunodiagnostics Box: 4 vials; 1-1.5 mL 10/19/2012
Products Testosterone Range each.
Verifiers (Low and High).
Restek................................ Custom Revised Appendix IX Mix Glass vial: 1.3 mL...... 2/14/2013
1.
Restek Corporation.................... Product and Reactor Samples Ampule: 2 mL............ 10/12/2012
Standard.
Restek Corporation.................... 8270 Supplemental Standard Ampule: 2 mL............ 12/13/2012
1.
Siemens Healthcare Diagnostics Inc.... TTST Stock X (Bulk)........... Stock container: 50 mL-1 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... VS TTST Cal Bulk Soln Level 1. Bulk container: 4 mL-100 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... VS TTST Cal Bulk Soln Level 2. Bulk container: 4 mL-100 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... VS TTST Cal Bulk Soln Level 3. Bulk container: 4 mL-100 7/26/2012
L.
[[Page 40184]]
Siemens Healthcare Diagnostics Inc.... VS TTST Cal Bulk Soln Level 4. Bulk container: 4 mL-100 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... VS TTST Cal Bulk Soln Level 5. Bulk container: 4 mL-100 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... VS TTST Cal Bulk Soln Level 6. Bulk container: 4 mL-100 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... Dimension Vista TTST CAL A.... Vial: 1 mL.............. 7/26/2012
Siemens Healthcare Diagnostics Inc.... Dimension Vista TTST CAL B.... Vial: 1 mL.............. 7/26/2012
Siemens Healthcare Diagnostics Inc.... Dimension Vista TTST CAL C.... Vial: 1 mL.............. 7/26/2012
Siemens Healthcare Diagnostics Inc.... Dimension Vista TTST CAL D.... Vial: 1 mL.............. 7/26/2012
Siemens Healthcare Diagnostics Inc.... Dimension Vista TTST CAL E.... Vial: 1 mL.............. 7/26/2012
Siemens Healthcare Diagnostics Inc.... Dimension Vista TTST CAL F.... Vial: 1 mL.............. 7/26/2012
Siemens Healthcare Diagnostics Inc.... Dimension Vista System TTST Box: 12 vials; 1 ml each 7/26/2012
CAL.
Siemens Healthcare Diagnostics Inc.... MP TTST Lvl 1 Bulk............ Bulk container: 4 mL-20 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... MP TTST Lvl 2 Bulk............ Bulk container: 4 mL-20 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... MP TTST Lvl 3 Bulk............ Bulk container: 4 mL-20 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... MP TTST Lvl 4 Bulk............ Bulk container: 4 mL-20 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... MP TTST Lvl 5 Bulk............ Bulk container: 4 mL-20 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... MP TTST Lvl 6 Bulk............ Bulk container: 4 mL-20 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... MP TTST CAL Lvl 1 FC.......... Vial: 1-5 mL............ 7/26/2012
Siemens Healthcare Diagnostics Inc.... MP TTST CAL Lvl 2 FC.......... Vial: 1-5 mL............ 7/26/2012
Siemens Healthcare Diagnostics Inc.... MP TTST CAL Lvl 3 FC.......... Vial: 1-5 mL............ 7/26/2012
Siemens Healthcare Diagnostics Inc.... MP TTST CAL Lvl 4 FC.......... Vial: 1-5 mL............ 7/26/2012
Siemens Healthcare Diagnostics Inc.... MP TTST CAL Lvl 5 FC.......... Vial: 1-5 mL............ 7/26/2012
Siemens Healthcare Diagnostics Inc.... MP TTST CAL Lvl 6 FC.......... Vial: 1-5 mL............ 7/26/2012
Siemens Healthcare Diagnostics Inc.... TTST Stock S (Bulk)........... Stock container: 50 mL-1 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... TTST Stock T (Bulk)........... Stock container: 50 mL-1 7/26/2012
L.
Siemens Healthcare Diagnostics Inc.... Estradiol Diluent............. Plastic container: 0.5L- 11/14/2012
1.0L.
Siemens Healthcare Diagnostics Inc.... Dimension Vista Drug 1 CAL Plastic test tube: 15 mL 12/3/2012
Pilot, Level B.
Supelco, Inc.......................... Titan C18 Batch Test 1 Mix.... Glass ampule: 1 mL...... 2/28/2013
----------------------------------------------------------------------------------------------------------------
The Deputy Assistant Administrator has found that each of the
compounds, mixtures, and preparations described in Chart II below is
not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and
in 21 CFR 1308.23. Accordingly, the Deputy Assistant Administrator has
determined that the chemical preparations or mixtures generally
described in Chart II below and specifically described in the
application materials received by DEA, are not exempt from application
of any part of the CSA or from application of any part of the CFR, with
regard to the requested exemption pursuant to 21 CFR 1308.23, as of the
date listed below that was provided in the determination letters to the
individual requesters.
Chart II
----------------------------------------------------------------------------------------------------------------
Application
Supplier Product name Form date
----------------------------------------------------------------------------------------------------------------
Agilent Technologies.................. Forensic Toxicology Ampule: 1 mL............ 12/6/2012
Comprehensive Mix-Submix 9A.
[[Page 40185]]
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 10/11/2012
Control Urine, MC177.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 10/23/2012
Control Urine, MC178.
Biochemical Diagnostics, Inc.......... Salivabuse Custom Liquid Glass vials: 1 ml-200 mL 10/23/2012
Control Oral Fluid, OF24.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 12/14/2012
Control Urine, MC180.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 12/14/2012
Control Urine, MC181.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-2 L... 1/22/2013
Control Urine, MC182.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-200 mL 1/29/2013
Control Urine, MC180.
Biochemical Diagnostics, Inc.......... Detectabuse Custom Liquid Glass vials: 1 ml-2 L... 2/14/2013
Control Urine, MC182.
Cerilliant Corporation................ (-)-11-nor-9-Carboxy-delta9- Glass ampule: 5 mL...... 7/6/2012
THC (1 mg/mL).
Cerilliant Corporation................ Cocaine HCl (10 mg/mL)........ Glass Ampule: 1 mL...... 7/6/2012
Cerilliant Corporation................ Lacosamide (10 mg/mL)......... Glass Ampule: 1 mL...... 9/12/2012
Cliniqa Corporation................... TDM Control, Levels 1-3 Bulk.. Plastic Container: 500 L 12/4/2012
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, THC Glass vial: 5 ml-4 L.... 8/9/2012
(0.5-50 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, Glass vial: 5 ml-4 L.... 8/9/2012
Methamphetamine (2-200 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, Glass vial: 5 ml-4 L.... 8/9/2012
Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2-
200 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Controls, Glass vial: 5 ml-4 L.... 8/9/2012
Multidrug (selected from THC,
Cocaine/Benzoylecgonine,
Amphetamines, Opiates, & PCP
at 0.5-50 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 8/9/2012
THC (0.5-50 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 8/9/2012
Methamphetamine (2-200 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 8/9/2012
Amphetamine, Benzoylecgonine,
Morphine, Phencyclidine (2-
200 ng/mL).
ElSohly Laboratories, Inc............. ELI Oral Fluid Calibrators, Glass vial: 5 ml-4 L.... 8/9/2012
Multidrug (selected from THC,
Cocaine/Benzoylecgonine,
Amphetamines, Opiates, & PCP
at 0.5-200 ng/mL).
LGC Limited........................... LAMPA (Lysergic Acid N-Methyl- Glass vial: 1 mL........ 11/30/2012
N-propylamide) 1.0 mg/mL in
Acetonitrile.
LGC Limited........................... LSD (Lysergic Acid Glass vial: 1 mL........ 11/30/2012
Diethylamide) 1.0 mg/mL in
Acetonitrile.
LGC Limited........................... LSD-D3 (Lysergic Acid Glass vial: 1 mL........ 11/30/2012
Diethylamide-D3) 0.1 mg/mL in
Acetonitrile.
LGC Limited........................... (-)-Cannabidiol 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... Cannabinol 1.0 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
LGC Limited........................... (-)-delta9-THC (Dronabinol) Glass vial: 1 mL........ 11/30/2012
1.0 mg/mL in Methanol.
LGC Limited........................... (-)-delta9-THC-D3 (Dronabinol- Glass vial: 1 mL........ 11/30/2012
D3) 0.1 mg/mL in Methanol.
LGC Limited........................... trans-11-Hydroxy-delta9-THC Glass vial: 1 mL........ 11/30/2012
((6aRS,10aRS)-11-Hydroxy-
delta9-tetrahydrocannabinol)
0.1 mg/mL in Methanol.
LGC Limited........................... trans-11-Hydroxy-delta9-THC Glass vial: 1 mL........ 11/30/2012
((6aRS,10aRS)-11-Hydroxy-
delta9-tetrahydrocannabinol)
1.0 mg/mL in Methanol.
LGC Limited........................... trans-11-Hydroxy-delta9-THC-D3 Glass vial: 1 mL........ 11/30/2012
(trans-11-Hydroxy-delta9-
tetrahydrocannabinol-D3) 0.1
mg/mL in Methanol.
LGC Limited........................... trans-11-Nor-9-carboxy-delta9- Glass vial: 1 mL........ 11/30/2012
THC 0.1 mg/mL in Methanol.
LGC Limited........................... trans-11-Nor-9-carboxy-delta9- Glass vial: 1 mL........ 11/30/2012
THC-D3 0.1 mg/mL in Methanol.
LGC Limited........................... trans-11-Nor-9-carboxy-delta9- Glass vial: 1 mL........ 11/30/2012
THC-D3 1.0 mg/mL in Methanol.
LGC Limited........................... Fentanyl 0.1 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Fentanyl 1.0 mg/mL in Methanol Glass vial: 1 mL........ 11/30/2012
LGC Limited........................... Fentanyl-D5 0.1 mg/mL in Glass vial: 1 mL........ 11/30/2012
Methanol.
Siemens Healthcare Diagnostics Inc.... Dimension Vista Drug 1 CAL Plastic container: 4-100 12/3/2012
Bulk, Level B. L.
----------------------------------------------------------------------------------------------------------------
Scope of Approval
The exemptions are applicable only to the precise preparation or
mixture described in the application submitted to DEA in the form(s)
listed in this order and only for those sections of the CSA and the CFR
that are specifically identified. Pursuant to 21 CFR 1308.24(h), any
change in the quantitative or qualitative composition of the
preparation or mixture or change in the trade name or other designation
of the preparation or mixture after the date of application requires a
new application. Pursuant to 21 CFR 1308.24(g), DEA may prescribe
requirements other than those set forth in 1308.24(b)-(e) on a case-by-
case basis for materials exempted in bulk quantities. Accordingly, in
order to limit opportunity for diversion from the larger bulk
quantities, DEA has determined that each of the exempted bulk products
listed in this order may only be used by the manufacturer and may not
be distributed by the manufacturer for any purpose or transported to
other facilities.
Additional exempt chemical preparation requests received between
July 1, 2012, and March 31, 2013, and not otherwise referenced in this
order may remain under consideration until DEA receives additional
information required, pursuant to 21 CFR 1308.23(d), as detailed in
separate correspondence to individual requesters. DEA's order on such
requests will be communicated to the public in a future Federal
Register publication.
DEA also notes that these exemptions are limited to exemption from
only those sections of the CSA and the CFR that are specifically
identified in 21 CFR
[[Page 40186]]
1308.24(a). All other requirements of the CSA and the CFR apply,
including, but not limited to, registration as an importer as required
by 21 U.S.C. 957.
Chemical Preparations Containing Newly Controlled Substances
The statutory authority for exempt chemical preparations is based
on the control status of substances contained within a preparation, the
intended administration of a preparation, and the packaged form of a
preparation. DEA conducts a case-by-case analysis of each application
for exemption to determine whether exemption of a preparation from
certain provisions of the CSA is appropriate pursuant to the specified
statutory and regulatory requirements.
Most exempt chemical preparations have remained effective until the
holder of a specific exempt chemical preparation specifically requested
that the exemption be terminated. The CSA allows for modifications to
the controlled substances schedules to add, remove, or change the
schedule of substances thus resulting in periodic modifications to the
control status of various substances. 21 U.S.C. 811(a). Since the CSA
was enacted in 1970, DEA has on several occasions added to, removed
from, or modified the schedules of controlled substances in accordance
with the CSA. Such changes may result in the non-compliance of exempt
chemical preparations with current statutes or regulations if chemical
preparations that have already obtained exempt status contain newly
controlled substances. For example, although an exempt chemical
preparation may continue to be packaged in the same manner as when it
was approved, non-controlled substances in the preparation may become
controlled, thus prompting the need for a new application for exemption
of the chemical preparation to ensure continued compliance. Other
preparations that previously contained no controlled substances may
contain newly controlled substances and thus would require an
application for exemption.
DEA reviews applications for chemical preparation exemptions based
on the statutes and regulations that are in place at the time of the
application, including the control status of substances included in the
preparation. DEA must remain vigilant to ensure that exempt chemical
preparations remain consistent with the standards set forth in the CSA
and its implementing regulations. As such, DEA reminds the public that
any chemical preparation, regardless of whether it was previously
exempt, that contains a newly controlled substance will require a new
application for exemption pursuant to 21 U.S.C. 811(g)(3)(B) and 21 CFR
1308.23-1308.24.
Review of Exemptions Pursuant to 21 U.S.C. 811(g)(3)
Based on inquiries received from industry, DEA is conducting a
comprehensive review of the exempt chemical preparation regulations.
DEA's regulations at 21 CFR 1308.24(a) state that approved chemical
preparations are exempt from certain provisions of both Subchapter I
and Subchapter II of the CSA: ``The chemical preparations and mixtures
approved pursuant to 1308.23 are exempt from application of sections
302, 303, 305, 306, 307, 308, 309, 1002, 1003 and 1004 of the Act (21
U.S.C. 822-823, 825-829, 952-954) and 1301.74 of this chapter, to the
extent described in paragraphs (b) to (h) of this section.'' Pursuant
to its regulations, DEA has provided exemptions from the application of
section 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 of the
Act (21 U.S.C. 822-823, 825-829, 952-954) and 21 CFR 1301.74 since the
implementation of the regulations in the early 1970s. Until DEA's
analysis of the exemption regulations is complete, DEA will continue to
review and provide exemptions to chemical preparations consistent with
the implementing regulations, when warranted. DEA will publish a future
notice regarding the outcome of DEA's review of its regulations with
respect to the exemption of chemical preparations.
Opportunity for Comment
Pursuant to 21 CFR 1308.23, any interested person may submit
written comments on or objections to any chemical preparation in this
order that has been approved or denied as exempt. If any comments or
objections raise significant issues regarding any finding of fact or
conclusion of law upon which this order is based, the Deputy Assistant
Administrator will immediately suspend the effectiveness of any
applicable part of this order until he may reconsider the application
in light of the comments and objections filed.
Approved Exempt Chemical Preparations Are Posted on DEA's Web Site
A list of all current exemptions, including those listed in this
order, is available on DEA's Web site at https://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The
dates of applications of all current exemptions are posted for easy
reference.
Dated: June 17, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2013-16010 Filed 7-2-13; 8:45 am]
BILLING CODE 4410-09-P
